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ABSTRACT 
 
 
 
Characterization of the 3' Terminal 42 Nucleotide Host Protein Binding Element of the 
Mouse Hepatitis Virus 3' Untranslated Region. (May 2003) 
Reed Findley Johnson, B.S., Kansas State University 
Chair of Advisory Committee: Dr. Julian Leibowitz 
 
Mouse hepatitis virus (MHV) is a member of the coronavirus family in the order 
Nidovirales.  The 32 kb genome contains cis-acting sequences necessary for replication 
of the viral genome.  Those cis-acting sequences have been shown to bind host proteins, 
and binding of those proteins is necessary for virus replication.  One of the cis-acting 
elements is the 3' terminal 42 nucleotide host protein binding element.  Previous work 
has demonstrated that mitochondrial aconitase, mitochondrial heat shock protein 70, heat 
shock protein 60 and heat shock protein 40 bind to the 3' terminal 42 nucleotide host 
protein binding element.  We demonstrated that RNA secondary structure of the 3' 
terminal 42 nucleotide host protein binding element is necessary for host protein binding 
in vitro.  We also demonstrated that primary structure of the 3' terminal 42 nucleotide 
host protein binding element is necessary for viral replication by targeted recombination.  
DI replication assays infer that the 3' terminal 42 nucleotide host protein binding element 
plays a role in positive strand synthesis from the negative strand template.  Current 
studies involve the infectious cDNA clone, which will provide definitive answers on the 
role of the 3' terminal 42 nucleotide host protein binding element in MHV replication. 
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1CHAPTER I 
INTRODUCTION 
 
Background 
Mouse hepatitis virus taxonomy.  Mouse hepatitis virus (MHV) is a member of the 
family coronaviridae of the recently introduced order nidovirales (20).  The other 
nidovirus family members are the toroviruses and arteriviruses.  Corona- arteri- and toro- 
viruses were organized into the same family because all have a positive sense, single 
stranded, RNA genome, similar RNA dependent RNA polymerase organization, and a 3' 
co-terminal nested mRNA structure (14).  Arteriviruses are smaller than coronaviruses 
and toroviruses with enveloped virions containing icosahedral nucleocapsids and 
measure 50-75 nm in diameter and lack surface projections that are found in corona- and 
toroviruses (20).  Arterivirus genomes are smaller as well, 13-15 kb, examples are 
porcine reproductive respiratory syndrome virus, equine arterivirus, lactate 
dehydrogenase elevating virus, and simian hemorrhagic fever virus.  The toroviruses, 
which include bovine torovirus, equine torovirus, human torovirus, Bredavirus, and 
porcine torovirus, vary from corona- and arteriviruses because toroviruses lack a 5' 
leader sequence, have a tubular capsid structure, and the M protein, which is functionally 
similar to coronavirus M proteins, is not glycosylated (14).  Toroviruses are 
pleiomorphic, measure 120-140 nm in diameter, and have surface projections that 
resemble coronavirus surface projections.  Torovirus genomes range in size from 20-25 
kb.  Coronaviruses are the largest single stranded RNA virus genomes known, the 
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genomes range in size from 23-31 kb (14).  Coronaviruses have a helical nucleocapsid 
and are 100-120 nm in diameter and have a “corona” of peplomers, composed of spike 
protein which acts as the ligand for host cell receptors. 
 The coronaviruses are made up of 3 distinct groups based upon organization of 
nonstructural proteins, antigenic properties, and the processing of the spike protein into 
two halves (14).  The group 1 coronaviruses include canine coronavirus, feline infectious 
peritonitis virus, human coronavirus 229E, and transmissible gastroenteritis virus.  The 
group I coronaviruses may process spike protein into S1 and S2 portions and some 
species express a hemagglutinin esterase protein in reading frame 2, group 1 viruses also 
use aminopeptidase N as a receptor for entry into host cells and may have two open 
reading frames after the nucleocapsid gene (14, 100).  The group 2 coronaviruses include 
bovine coronavirus, human coronavirus OC43, rat coronavirus, and mouse hepatitis 
virus (MHV).  Group 2 viruses process spike protein into S1 and S2 portions and some 
strains of some species will express a hemagglutinin esterase as a possible co-receptor.  
Group 3 coronaviruses include infectious bronchitis virus, and turkey coronavirus.  
Group 3 viruses process spike protein and do not express a hemagglutinin esterase, they 
also vary from group 1 and 2 due to the presence of open reading frames between genes 
M and N. 
The human coronaviruses are known to cause diarrhea, gastroenteritis, and 
necrotizing enterocolitis (79, 81, 103).  Human coronaviruses have been associated with 
multiple sclerosis, OC43 and 229E antigens have been located in CNS tissue from  
3 
1A
1B
2 HE S 4 E
5A M
I
N
3'UTR
5'UTR
Non-structural protein region                                      Structural protein region
Figure 1.  Schematic representation of the MHV genome.  The shaded regions
indicate the different reading frames for the MHV proteins produced.  The
rendering is not to scale as the the ORF 1A and IB reading frames comprise
nearly 2/3 of the MHV genome.  The dark boxes between the reading frames
indicate aTRS sequence.  The boxes at the termini of the genome indicate the
untranslated regions.
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human multiple sclerosis patients (13).  MHV can cause an encephalomyelitis in mice 
depending upon the infecting strain and serves as a mouse model for multiple sclerosis 
(22).  Intracerebral inoculation of weanling mice with MHV-JHM results in a 
demyelinating disease with lesions that can be seen as early as 4 weeks (48). 
MHV genome organization.  The MHV genome is organized into a 5' non-structural 
protein region and a 3' structural protein region and acts as a messenger RNA when 
introduced into a host cell.  See Figure 1.  The genome is capped, poly-adenylated, and 
codes for seven mRNA’s which are responsible for at least 7 proteins (92).  See Figure 
2.  RNA’s 5 and 7 each have two open reading frames (ORF’s) (23, 111).  Messenger 
RNA 1, which is genome length, contains two overlapping reading frames ORF 1a and 
ORF 1b that generate a 740 KDa polyprotein which is then cleaved post- and co-
translationally (12).  Genes 2 through 7 encode the structural proteins and two 
nonstructural proteins.  Each gene is separated by a short intergenic sequence, the 
transcriptional regulatory sequence (TRS), which acts as a cis-regulator of transcription.  
The TRS’s precise role in transcription is debated and will be covered in the section on 
MHV transcription.  The genomic TRS regions have a UCUAA nucleotide motif 
repeated varying number of times depending upon the gene (101).  Each of the 7 
mRNA’s carry a 72nt leader sequence derived from the 5' end of the genome and a co-
terminal 3' UTR.  Only the 5' unique region of each mRNA is translated. 
MHV proteins.  The non-structural genes are coded by mRNA 1, which is the full-
length infectious mRNA and codes for the RNA dependent RNA polymerase and 
associated proteins which are co- and post- translationally processed.  The coding region  
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mRNA 1, 32 kb  (10.4)
mRNA 2, 9.6 kb  (4.7)
mRNA3, 7.5 kb  (4.2)
mRNA 4,  3.4 kb  (6.5)
mRNA 5, 3.1 kb  (13.1)
mRNA 6, 2.4 kb  (15.7)
mRNA 7, 1.7 kb (45.5)
Figure 2.  Organization of the subgenomic mRNAís of MHV, protein functions 
are described in text, sizes and relative molar abundance are listed.  The hashed 
region indicates the ORF of each mRNA, the leader sequence is the dark box at 
the 5í end of each mRNA.  The alternate reading frame of each mRNA is also 
indicated by a black box. The grey box indicates the 3í UTR that is present on 
each mRNA.  The figure is not to scale.
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comprises nearly two-thirds of the genome and is composed of two overlapping ORF’s. 
The –1 frameshift that allows for the switch to ORF 1B is mediated by a pseudoknot and 
alignment of a 7 nucleotide sequence (12).  The polyprotein is thought to function as the 
RNA dependent RNA polymerase of the virus and as many as 8 functions are associated 
with the mRNA polyprotein as determined by complementation analysis (96).  ORF 1a 
encodes 2 papain like protease domains and a picornavirus like 3C protease (10).  ORF 
1b contains a helicase domain and an NTP binding domain and is most likely the core 
unit of the RNA dependent RNA polymerase (50).  See Figure 2 for MHV protein 
assignments. 
 Two mRNA’s are produced from gene 2 in most MHV strains.  The first mRNA, 
mRNA –2 produces a 30kDa nonstructural protein whose role in the virus lifecycle is 
not understood (11).  The second mRNA is only expressed in some MHV strains.  It 
encodes a hemaggluttinin-esterase (HE), which acts as a secondary receptor and may be 
involved in tissue tropism.  It is not expressed in A59 strain due to a deletion of the 
initiating methionine (58).  A59 is mildly hepato- and neuro- tropic, but it is variably 
expressed in the neurotropic JHM strain.  MHV-3 does not express HE and is 
predominantly hepatotropic.  The variability of expression of hemagglutinin esterase in 
neurotropic and hepatotropic strains makes it hard to pinpoint a role for HE as a co-
receptor or a factor in determining tissue tropism. 
 The major ligand for the host-cell receptor is the spike protein expressed by 
mRNA 3.  Spike protein binds to CEACAM 1, which is a type 1 membrane spanning 
protein, of host cells.  Spike exists as two portions S1 and S2 that are not covalently 
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associated (26, 59).  S1, which has no membrane spanning region, and resides on the 
outer surface of a mature virion, is a target for neutralizing antibodies that provide 
protective immunity (44).  S2 also acts as a target for neutralizing antibodies and 
contains a membrane-spanning portion (16, 18).  Antibodies raised to S2 will block 
syncytia formation in infected cells and lowers virus yield.  Lai’s group isolated an A59 
mutant that had amino acid 159 changed from a glutamic acid to lysine that grew well in 
tissue culture but its role in a live animal was not fully explored.  Weiss’s group 
introduced this mutation into MHV-A59 using Masters’ feline infectious peritonitis virus 
spike protein based targeted recombination system.  Studies of the engineered mutant 
indicate that the Q159L mutation in spike protein decreased hepatotropism and 
attenuated MHV-A59’s ability to induce demyelination, reinforcing the spike proteins 
role in tissue tropism and disease progression (51). 
 The fourth mRNA codes for a non-structural protein of undetermined function.  
The role of the 139 amino acid product of gene 4 in the MHV lifecycle is a mystery, 
although a knockout virus was produced by targeted recombination.  The gene 4 
knockout virus exhibited no difference in growth kinetics, had similar CPE, and no 
change in titer when grown in tissue culture.  When the gene 4 knockout virus was 
introduced in mice there was no apparent change in pathology when compared to MHV-
JHM infected mice (73).  A second study also using targeted recombination to produce a 
gene 4-ORF 5a knockout virus showed only a slight decrease in titer in tissue culture 
cells.  Upon challenging mice, mortality due to virus infection was reduced when 
compared with wild-type infected controls.  The 7-day post infection mice however did 
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exhibit clinical signs of infection suggesting that the 4-5a knockout virus is attenuated in 
mice (19).  Although the specific function of gene 4 is unknown it is apparent that gene 
4 plays a role in pathogenicity of MHV-JHM. 
The fifth mRNA has two alternate reading frames, ORF 5a and ORF 5b. ORF 5a 
is not expressed in tissue culture, but may be necessary for infection of an animal.  
ORF5b is preferentially expressed in tissue culture, and encodes a third membrane 
protein, E, that is required for formation of virion particles (24, 111).  E is an integral 
membrane protein whose amino terminus is highly hydrophobic and buried in the 
membrane of virion envelopes, the carboxy terminus extends into the virion and may 
interact with other viral structural proteins (60).  E has also been shown to induce 
apoptosis in MHV infected 17Cl-1 cells and expression of E protein by recombinant 
vaccinia virus constructs also induced apoptosis in DBT cells (4). 
The sixth mRNA codes for M protein which is a membrane spanning protein 
required for virion assembly.  Some antibodies targeted to M are neutralizing in the 
presence of complement (25).  M protein has been shown to interact with genome 
associated N protein in pre-Golgi complexes, which is the site of virion assembly and 
release (69).  Work by Nguyen and Hogue demonstrated that BCoV M interacts with HE 
and S proteins in the ER or IC shortly after protein synthesis begins and suggests M’s 
role in organizing assembly of the virion.  However, another study of M protein failed to 
show an interaction of M with S and E using MHV and Sindbis virus constructs 
expressing MHV proteins but supported the N and M interaction (69).  The data from 
both studies indicates that M and N interaction is necessary for virus growth and that M 
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serves as a “central organizer for virion assembly” as suggested by Nguyen and Hogue 
(70).  The difference in results concerning possible interactions of S and HE with M and 
N could be due to the methodology used and time points post infection studied.  
Nguyen’s work used BCoV and relied on pulse chase experiments followed by co-
immunoprecipitation of M, HE, and S, and immunofluorescence with antibodies to M, 
HE, and S, while Narayanan et al. used co-immunoprecipitation of M, N, and S from 
MHV infected cells, and co-infection with Sindbis virus constructs carrying the MHV 
proteins M, N, and S.  Both approaches are feasible and it is likely that the varying 
results are due in part to the virus used and the time course studied, a period of 1 hour at 
15 hours post infection for Nguyen and Hogue versus Narayanan’s work which only 
gave data for 8.5-9.0 hours post infection, but used MHV.  The data suggests that the 
interactions described in both experiments are reasonable and that M is necessary for 
structural viral protein interaction although the interaction may be transient.  Data to 
support M and N interaction and its role in virion formation has also come from Kuo and 
Masters.  A deletion mutant of the 2 carboxy terminal amino acids from M was 
constructed and exhibited M’s requirement for assembly (46).  Mutant viruses that were 
able to grow displayed a 103 decrease in viral titer and had small plaque sizes.  Revertant 
viruses that restored titer to near wild type levels were found to have mutations 
elsewhere in the M gene and also in the N gene but not in the E gene (46).  
 The seventh and most abundant mRNA is the nucleocapsid protein, which 
contains two reading frames, the first and predominately used reading frame codes for 
the nucleocapsid protein, N, which is the most abundant protein in infected cells and 
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mature virions.  N preferentially binds to genome length viral mRNA and has also been 
shown to bind to M protein to help form an intact virion.  N’s binding to RNA is 
determined by its phosphorylation state, when phosphorylated N will bind genomic 
RNA and when dephosphorylated by specific host cell phosphatases N releases RNA.  
This release of the RNA may act as one of the initial steps in replication (37).  The 
alternate reading frame encodes a small protein associated with the virion, I.  The precise 
role of I protein has not been identified, but using targeted recombination Fisher et. al 
were able to demonstrate that mutation of its reading frame did not deleteriously effect 
viral replication in tissue culture, but did not rule out a role in an infected animal (23). 
MHV transcription.  Transcription of the 7 MHV mRNA’s occurs through a poorly 
understood mechanism.  Currently there are three models that attempt to explain 
transcription.  See Figure 3.  The first model is leader-primed transcription (A. in Figure 
3), in this model the viral RdRp complex uses genome length complementary RNA as a 
template for transcription.  The leader, a 72 nt RNA has a 3' region that is 
complementary to the transcriptional regulatory sequence (TRS) on the full length 
negative strand.  The model proposes that the leader anneals to the intergenic regions of 
each of the genes and transcription proceeds to the 5' terminus of the negative strand.  
The resulting products are translationally active genomic and subgenomic mRNA’s that 
are 5' and 3' co-terminal (7, 62).  This model is supported by the presence of free leader 
RNA that would serve as a primer to transcription (7).  However, another model 
developed when subgenomic negative strand RNA’s were found in infected cells  
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(83, 87).  Brian’s group identified subgenomic negative strand RNA’s in TGEV infected 
cells by Northern blot analysis of denatured RNase resistant RNA molecules, their time 
course analysis demonstrates that subgenomic complementary strand RNA’s were 
produced prior to subgenomic mRNA production suggesting a role for the subgenomic 
complementary strand RNA’s as functional templates for mRNA synthesis.  This model 
depends upon premature termination in the generation of full length negative strand 
RNA’s that result in subgenomic negative strand RNA’s that contain the 5' and 3' cis-
acting elements present in the genome length RNA (B. in Figure 3).  These elements 
could then be recognized by host and viral factors necessary for positive strand synthesis 
producing positive strand subgenomic RNA’s.  The resulting subgenomic 
complementary strand RNA’s could then serve as active transcription templates by 
annealing of the 72 nt leader to the anti TRS in the complementary subgenomic RNA. 
The RdRp then extends towards the 3' end to produce subgenomic mRNA’s. 
 The third model, discontinuous transcription, uses the negative strand 
subgenomic length mRNA’s as transcription templates for subgenomic mRNA 
production.  In this model (C. in Figure 3) subgenomic complementary RNA’s are 
initiated from the 3' UTR of the MHV genome.  The complementary RNA is extended 
until an intergenic region is reached, the RNA molecule then dissociates and re-
associates at the 5' end of the genome where an anti-leader sequence is added, and the 
complete complementary subgenomic RNA then serves a transcription template.  The 
intergenic regions are thought to serve as transcriptional attenuators rather than 
transcription start sites as in the leader-primed mechanism.  Kinetic data indicates that 
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subgenomic complementary RNA’s are synthesized before subgenomic mRNA’s (83, 
84, 87).  Other support for the discontinuous mechanism comes from a study of 
temperature sensitive mutants from Schaad and Baric (85).  A temperature sensitive 
mutant of MHV was unable to produce subgenomic complementary RNA’s at the 
restrictive temperature and infection was impaired.  Upon switching the infected cells to 
the permissive temperature the temperature sensitive mutant would produce subgenomic 
complementary RNA’s and mRNA’s (85).  Regardless of mechanism, the temperature 
sensitive and kinetic data strongly suggest a role for the complementary subgenomic 
RNA’s to act as active transcription templates to produce viral mRNA’s. 
 Support for the discontinuous model of MHV replication comes from studies of 
the phylogenetically related arterivirus, equine arteritis virus (EAV).  An infectious 
cDNA of EAV has been developed and studied (102).  A point mutant in the replicase 
gene that converts a serine residue to proline at nucleotide position 7508 from the 5' end 
was found to be replication competent yet defective in production of subgenomic 
RNA’s.  Immuno-fluorescence assays using antibodies to NSP-2 (the EAV RdRp) 
indicated that the transfected viral RNA’s containing this point mutant replicated and 
translated, and metabolic labeling confirmed the synthesis of genome length positive 
strand RNA’s.  Metabolic labeling and RT-PCR of transfected cultures found that 
subgenomic mRNA’s were not synthesized except for a trace amount of mRNA 7 (102).  
These data alone fail to support discontinuous transcription, but demonstrate that 
transcription and replication are not coupled.  Further study of the EAV infectious clone 
demonstrated that specific base pairing of the leader 3' sequence to body complementary 
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mRNA’s is required for subgenomic mRNA synthesis (74).  Mutagenesis of the leader 
TRS 3' sequence without a compensatory mutation in the body complement strand 
yielded viral genomes that still replicated but were transcription defective.  The 3' end of 
the leader TRS is thought responsible for the RNA:RNA interaction and serves as the 
initiating event in transcription.  Sequencing of the lower yield mRNA’s indicated that 
the TRS in the subgenomic mRNA’s is derived from the body TRS and not the leader 
TRS.  The only mRNA that was still produced was mRNA 3, but that was transcribed 
using a different repeat of the 3' TRS sequence.  Infectious clones that contained 
complementary base pairs in the positive sense leader and the complementary TRS 
strand did not have any defects in transcription or replication supporting the role of 
proper base-pairing of the leader and the body complement RNA for transcription.  
These data support the discontinuous model because they show that the subgenomic 
complementary TRS body sequence is present in the mRNA’s produced which supports 
the model for discontinuous transcription of MHV by giving evidence that the 
complementary strand RNA is used as a template, and that specific interactions between 
the 3' end of the leader RNA and the TRS in the complementary subgenomic mRNA’s 
are functional. 
MHV replication.  MHV replication is thought to occur shortly after entry and 
uncoating of the virion through production of a full-length negative strand intermediate.  
Negative strand RNA’s have been detected by ribonuclease protection assays as early as 
one hour 20 minutes post infection (55).  The negative strand intermediate then serves as  
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Figure 4.  Schematic of defective interfering RNA' s MIDI, DIssE, 
and DI B36, indicating the regions of the genome from which each
DI is derived. 
 16 
a template for the RNA dependent RNA polymerase (RdRp) to generate full length 
genomic RNAs.  The negative strand RNA is probably produced by the RdRp’s 
recognition of loosely identified signals in the 3' UTR of the positive strand genomic 
RNA, possibly mediated by RNA sequence and/or conformation and interaction of host  
factors.  Using DI replication studies, Lin et al identified the 3' terminal 55 nucleotides 
as a requirement for negative strand synthesis, but did not further characterize which 
nucleotides were required or if any host or viral proteins specifically interacted with the 
3' terminal 55 nucleotide element (55).  After recognition of signals in the 3' UTR, the 
RdRp produces a full-length negative strand RNA molecule.  Replication is thought to 
occur on smooth membranes of cells, possibly on the intermediate compartment (IC), 
which is thought to be the release site of mature virions (92).  Recent studies have shown 
replication complexes forming on the smooth membranes of cells including the 
lysosome, but not specifically on the IC (21)  
To date MHV replication has been studied through the use of defective 
interfering RNA’s.  DI RNA’s are RNA molecules that contain portions of the genome, 
which are sufficient for replication in the presence of helper (wild type) virus.  DI 
RNA’s are thought to originate as a result of recombination events that give rise to RNA 
molecules of varying sizes and compositions that contain the necessary cis-acting signals 
for replication.  The major DI’s used for replication studies are DIssE, MIDI, and B36.  
See Figure 4.  DIssE has been used extensively and has probably provided more data on 
cis-acting replication signals than the other DI’s.  DIssE is a 2.2 kb, naturally occurring 
DI, which was isolated from serial passage of MHV-JHM (61).  DIssE is composed of 3  
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Figure 5.  DIssE is derived from the regions of the MHV genome
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necessary for replication of DIssE.
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regions from the MHV-JHM genome.  Region one is from nts 1-864, region II is derived 
from a 784 nt internal region originating from 3.3 to 4 kb from the 5' end of the genome, 
and region III is derived from the 601 3' terminal nucleotides.  Studies of DIssE mutants  
have identified several regions required for DI replication: the 5' terminal 474 nts are 
necessary for replication as is a 58 nt element derived from region II, and the 3' terminal 
436 nts are also needed (5, 41, 61).  See Figure 5.  A recent study of MIDI-C by 
Spagnolo and Hogue demonstrated that at least 5 A residues in the poly (A) tail are 
required for replication and the poly (A) tail formation (93).   
Studies focusing on the 3' UTR have shown that RNA secondary structure is 
necessary for replication of DI RNA’s.  A study of the 5' end of the 3' UTR by Master’s 
lab suggests that a cis-acting 68 nt bulged-stem-loop predicted to contain 6 stem-loop 
regions is required for DI replication and that secondary structure of the bulged-stem-
loop is essential for viral replication (34). Using targeted recombination to generate 
mutant viruses of the 68 nt bulged stem-loop Hsue et al. demonstrated that primary and 
secondary structure were important for viral replication (33).  Mutations were made in 
the left arm (or 5' segment of bulged-stem-loop) and the right arm (or 3' segment of the 
bulged–stem-loop) or both of each of the 6 stem regions and evaluated for their ability to 
replicate.  Those mutants that could not be engineered by targeted recombination were 
explored by DI replication assays using DI B36.  Chemical and enzymatic probing of the 
68 nt stem-loop indicated that the original prediction was incorrect and that only 4 stem-
loop structures are present.  Chemical and enzymatic probing demonstrated that stem-
loop A did not exist and that the nucleotides involved in stem A were predicted to be  
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Figure 6. The stem loop structure adjacent to the N gene 
stop codon.  The stem loop is at the 5' end of the 3' UTR.  
The stem loop regions are indicated by the upper-case 
letter on the left side of the stem-loop structure and each 
regions role in replication is discussed in the text.  
Previous predictions indicate two more stem-loop 
structures, but chemical and enzymatic probing does not 
support their formation.
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unpaired and form a larger loop than earlier predicted the loop region of stem-loop B in 
Figure 6.  Mutagenesis of stem B showed that primary and secondary structure could be 
altered with no effect on replication ability of the DI.  The primary sequence of stem- 
loops C and D could be disrupted, but as long as wild type secondary structure was intact 
the recombinant virus was viable.  Stem E was also non-existent based upon chemical 
and enzymatic probing and is now predicted to be unpaired and is thought to form a 
large internal loop (between D and F in Figure 6). Mutagenesis of stem F indicated that 
mutating either the left or right arm was deleterious to replication. Stem F is thought to 
be critical for forming an RNA:RNA interaction with a pseudoknot structure identified 
by David Brian’s lab (105).  
Brian’s lab identified a pseudoknot structure in the 3' UTR of BCoV immediately 
downstream of Masters’ 68 nt stem-loop structure (105).  An earlier study by Hsue and 
Masters showed that the 3' UTR’s of MHV and BCoV were functionally interchangeable 
and share high homology (34). Mutagenesis of the nucleotides thought responsible for 
the RNA:RNA interaction resulted in decreased replication of the DI RNA’s studied, 
supporting the role for a highly conserved tertiary structure, mediated by proper 
secondary structure to function in viral replication. See Figure 7. 
Recently Liu et al used limited ribonuclease digestion and computer modeling to 
define the secondary structure of the 3' terminal 166 nucleotides (57).  Digestion data 
and computer modeling demonstrate that the 3' terminal 166 nucleotides form multiple 
stem-loop structures.  DIssE mutants were developed that would disrupt base pairing in  
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Figure 7.  Schematic representation of the defined secondary structures 
of the MHV 3' UTR including the psuedoknot identified in BCoV.  The 
nucleotide positions are arranged so that position 1 is the first nucleotide 
5' to the poly A tail.
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the stem sections of the model and tested for effects on DIssE replication.  When 
clustered point mutations were made in either arm of a stem segments AQ and BQ DIssE 
would not replicate as well and would occasionally recombine to restore wild type 
primary structure.  Mutations in CQ replicated about as well as wild type and were not  
investigated further.  See Figure 7.  When compensatory mutations, which should restore 
base pairing, were introduced DI replication could be restored to near wild type levels 
and in a couple of individual experiments compensatory mutant DI replication exceeded 
wild type DIssE replication, supporting a role for RNA secondary structure in MHV 
replication. 
Host proteins have been shown to interact with the regions involved in the 
secondary and tertiary structures described but not specifically with the proposed stem-
loop and pseudoknot structures. Whether or not the RNA structures actually play a role 
in host protein binding for the 68 nt stem-loop or the pseudoknot has not been tested.  
Data from Leibowitz’s lab indicates that host proteins bind to specific nucleotide motifs 
within the 3' UTR.  Leibowitz’s lab identified two host protein binding elements within 
the 3' terminal 166 nucleotides, secondary structure analysis of this region by computer 
modeling, limited ribonuclease digestion, and mutagenesis of DI’s directed at disrupting 
RNA secondary structure indicate that secondary structure influences replication (57).  
Mutation of the protein binding motifs was shown to decrease host protein binding by 
gel mobility shift RNase T1 protection assays.  When the same mutations were 
introduced into DIssE for DI replication assays, the mutant DI’s did not replicate as well 
or recombined to restore wild type primary structure, suggesting an importance for host 
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protein binding to a proper structure (either primary, secondary or both) (56, 109, 110).  
RNA conformation is not only important for the 3' UTR for replication, but in the 
internal 58 nucleotide region as well.  Work by Repass and Makino indicates that 
secondary structure of the internal 58 nucleotide region is necessary for replication (78).  
Mutagenesis of this region, using mutations designed to disrupt predicted secondary 
structure, indicated that secondary structure of the 58 nucleotide region played a role in 
DI replication.  DI’s carrying mutations that disrupted the proposed stem loop structure 
did not replicate as well as wild type DI’s. 
The role of host proteins binding to the MHV 3' UTR and the effect of binding 
on replication has been studied and is the major focus of this dissertation.  Previous 
MHV work has identified 7 proteins that bind to separate regions of the MHV 3' UTR 
and the proteins do play a role in replication.  See Figure 8.  Lai’s lab has shown that 
heterogenous ribonucleoprotein A1 (hnRNP-A1) binds to negative strand leader RNA’s 
and in MHV infected cells hnRNP-A1 translocates from the nucleus to the cytoplasm.  
HnRNP-A1’s normal role in the cell is for alternate splicing of cellular RNA’s in the 
nucleus.  Using mutant DIs Li et al were able to show that DIs with sequence that 
demonstrated decrease in hnRNP-A1 binding also showed a decrease in transcription of 
DI’s suggesting hnRNP-A1’s role in MHV transcription (53).  However, Shen and 
Masters demonstrated that hnRNP-A1 did not act as transcriptional enhancer, and that a 
cell line that does not normally express hnRNP-A1 could grow MHV without any 
deleterious effects (88).  Support for hnRNP-A1’s role in the MHV lifecycle comes from 
studying the overexpression of hnRNP-A1 that resulted in accelerated accumulation of  
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Figure 8.  Identified binding sites of known host proteins in the MHV genome 
and complementary RNA.  See text for details for each protein's rol e in the MHV 
lifecycle.  The numbers indicate the approximate nucleotide position each protein 
or protein complex binds.  The dark octagon indicates the stop codon for N gene.
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viral RNAs (90).  Using a carboxy terminal deletion mutant Lai’s lab also showed a 
dominant negative effect where transcription and replication were inhibited when 
compared to wild type cells.  The carboxy terminus of hnRNP-A1 is thought to be the 
RNA binding domain (90). 
HnRNP-A1 has also been shown to bind to the 3' UTR at positions 90-170 and 
260-350 from the 3' terminus excluding the polyA tail (36).  This region is 
complementary to the polypyrimidine tract binding protein (PTB) binding site in the 
complementary strand RNA.  Binding of the hnRNP-A1 to the 5' and 3' UTR’s as well 
as the location of binding suggested a possible role for mediating interaction of the 5' 
and 3' ends of the genome.  Support for the proposed cross-talk comes from using GST 
fusion proteins of hnRNP-A1 and PTB along with radiolabeled 3' UTR and biotinylated 
leader.  Probes were pulled down by streptavidin columns and the proteins that were 
pulled down were identified as PTB and hnRNP-A1.  Interestingly both RNA probes 
were needed to extract PTB and hnRNP-A1, either probe alone with both proteins did 
not pull down the other RNA supporting the necessity of all components to form a 
complex.  
PTB has been shown to bind to the complement of the 3' UTR (5' end of the 
complementary strand RNA molecule, the putative template for genome replication)  
PTB binding was shown to alter RNA secondary structure as tested by biochemical 
probing.  PTB was found to bind nucleotides 77-82, 132-136, and 270-305 from the 5' 
end of the complementary RNA. PTB has also been shown to bind to leader RNA’s and 
may play a role in transcription (52). Recent work by Choi et al demonstrated that 
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overexpression of PTB reduced transcription of MHV mRNA’s, but did not effect 
translation underlining PTB’s role in MHV transcription (17). 
Spagnolo and Hogue identified poly (A) binding protein (PABP) as binding to 
the 3' UTR plus poly (A) tail.  They demonstrated that at least 5 A residues of the poly A 
tail are required for PABP binding, when deleted the protein does not bind and DI 
replication is impaired, and in some experiments the poly A tail was repaired and 
replication did occur (93).  Spagnolo and Hogue also suggested that PABP may be 
involved in circularization of the MHV genome.  Previous work by Andino’s group has 
shown that PABP interaction is necessary for the circularization of the poliovirus 
genome, and that circularization is an essential step in the initiation of negative strand 
synthesis (32).  Further work on poliovirus has shown that circularization of the genome 
is also involved in translation (65, 97).  A study by Kuyumcu-Martinez et al. has shown 
that PABP specifically associated with polysomes is quickly degraded by poliovirus 3C 
protease (47).  Cleavage of PABP by 3C protease may act as a trigger for a switch from 
translation of genome length RNA to replication, which may not require genome 
circularization from negative strand templates.  It is possible that PABP binding to the 
MHV poly (A) tail is required for genome circularization and the initiation of negative 
strand synthesis as seen in poliovirus.  It is possible that PABP could be cleaved by one 
of the many uncharacterized nonstructural proteins produced by MHV or the 3C like 
protease encoded in ORF 1b, also acting as a trigger for switching from genome length 
translation to replication from negative strand templates. 
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Nanda and Leibowitz identified mitochondrial aconitase, mitochondrial HSP70 
as well as HSP60 and HSP40 as binding to the 3' terminal 42 nucleotide element within 
the 3' UTR (67, 68).  Two host protein binding elements in the 3' UTR were initially 
described by Yu and Leibowitz and further characterized by Liu, Yu and Leibowitz.  
The elements are at positions 166-129 and the 3' terminal 42 nucleotides, and within 
these two elements is an 11nt motif UGANRGAAGUU (56, 109, 110).  Mutagenesis of 
this motif resulted in decreased replication or recombination that restored wild type 
sequence in DIssE.  Computer based secondary structure modeling of the 3' 42 
nucleotide element suggests the formation of a stem-loop structure.  Liu’s digestion data 
does not provide any information on the terminal 12 nucleotides, but suggests the 
formation of a mostly single stranded, bulged-stem-loop structure which differs from the 
predominantly double stranded model proposed by Yu and Leibowitz (57, 109).  The 
role of secondary structure of the 3' 42 nucleotide element in binding to mitochondrial 
aconitase, mitochondrial HSP70, HSP60 and HSP40 and the effect of RNA 
conformation on viral replication has to date not been studied, and is the focus of this 
dissertation. 
 Mitochondrial aconitase has a cellular counterpart, the iron regulatory protein.  
IRP has a 30% amino acid identity and 56% overall amino acid sequence similarity to 
mitochondrial aconitase (39).  IRP is a conditional cytoplasmic mRNA-binding protein 
which interacts with iron-responsive elements located in the 5' UTR of ferritin mRNA 
and the 3' UTR of transferrin receptor mRNA and functions to coordinate post-
transcriptional regulation of cellular iron metabolism.  Iron starvation yields the active 
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RNA-binding form which binds to IREs of target RNA’s; when iron becomes scarce 
inside a cell the IRPs bind to the IRE in the 5' UTR of the ferritin mRNA which blocks 
ferritin translation.  IRP binding with IREs in the 3' UTR of transferrin receptor mRNA 
stabilizes this transcript and increases its subsequent translation to increase intra-cellular 
iron concentration.  Given the sequence and structural similarities between 
mitochondrial aconitase and the iron responsive protein Nanda and Leibowitz 
demonstrated that iron supplementation increased viral titer at early times post infection 
and that viral protein expression occurred earlier in infected, iron supplemented cells 
versus non-supplemented infected cells (68). 
 The role of secondary structure in replication as well as the specific purpose of 
host proteins binding to defined regions in the MHV genome is unknown.  It is possible 
that hnRNP-A1’s interaction with the negative strand leader and PTB’s binding to the 
positive strand leader may act as an initiation complex for viral replication or 
transcription.  PTB and hnRNP-A1 have been shown to associate in the spliceosome 
complex so it is possible that PTB recruits leader to hnRNP-A1 to begin transcription of 
MHV genes, a similar system may be used to recruit host and viral proteins to the 3' 
UTR to initiate replication.  Since the 3' terminal 55 nucleotides are necessary for 
negative strand synthesis it is possible that mitochondrial aconitase and its associates 
along with PABP bind to the 3' UTR changing RNA conformation which allows 
hnRNP-A1 to bind.  After or concurrently, the RdRp recognizes a signal either through a 
protein:protein interaction brought about by hnRNP-A1, PABP, mitochondrial aconitase 
complex binding, or an unknown host protein.  It is also possible that a RdRp:RNA 
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interaction occurs directly that is mediated through RNA conformational changes from 
host proteins binding to their specific regions of the 3' UTR.  Once the RdRp recognizes 
its signal in the 3' UTR (either protein or RNA structure) the complementary negative 
strand is produced and it is possible that PTB binds to help regulate the genome and 
complementary genome RNA interaction. 
The role of RNA secondary structure and the binding of host proteins to RNA 
secondary structures and their importance in viral life cycles has been described in other 
virus systems.  Hepatitis C undergoes internal ribosome entry site (IRES) dependent 
translation, disruption of the IRES, which is located in the 5' UTR, leads to a loss in 
translation and inhibition of viral growth (72).  It has been shown that eIF-3 subunit 
binds the IRES and without this interaction there is no translation of HCV RNA’s.  An 
HCV mutant was developed that maintained the wild type IRES secondary structure, but 
could not be translated.  The mutation was in the apical-stem loop of portion IIId of the 
IRES which binds ribosomal protein S9.  See Figure 9.  Investigation by enzymatic 
probing determined that the RNA in the apical stem-loop was not folded properly, when 
the wild type secondary structure of the apical stem-loop was restored it was found that 
S9 bound and translation of HCV RNA was restored (72).  Hepatitis C studies have 
demonstrated that the complementary RNA strand’s secondary structure is also 
important for replication of the genome.  A study of the HCV region complementary to 
the IRES region found that complementary IRES does not make a mirror image of the 
IRES.  Disruption of the complementary IRES structure prevents binding of the NS5B 
(HCV RdRp) and initiation of the production of genome sense RNA molecule (86).   
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Figure 9.  The 5' and 3' UTR' s of hepatitis C and the proteins that bind.
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The Hepatitis C genome has also been shown to bind many host proteins, 
although the exact function of each is currently under investigation.  See Figure 9.  
Polypyrimidine tract binding protein (PTB) has been shown by immuno-depletion and in 
vitro translation assays to be essential for translation of HCV genomes in vitro, and PTB 
has been shown to associate with the 5' UTR of HCV (2).  It has also been demonstrated 
that the La auto-antigen is required for translation as well (1).  Another study has 
suggested that Poly C binding protein (PCB) interacts with the HCV 5' UTR.  This study 
demonstrated that whole IRES is necessary for binding and extrapolated their data to 
indicate that secondary structure forms first then serves as a landing site for PCB.  The 
function of PCB’s binding to the 5' UTR is unknown (94). 
Host proteins binding to the 3' UTR has also been demonstrated for HCV.  See 
Figure 9.  It has been demonstrated that La also binds to the 3' UTR and protects HCV 
RNA from degradation (95).  HCV genome is not poly-adenylated, and poly-adenylation 
is thought to protect cellular RNA’s from degradation probably through binding of Poly 
A binding protein (PABP) and its associated complexes.  The mechanism of HCV RNA 
stability is unknown and work has demonstrated that La, PTB, and heteronuclear 
ribonucleoprotein C (hnRNP C) bind to regions within the 3' UTR.  Studies to determine 
the function of this binding found that La would protect RNA from degradation, while 
hnRNP C and PTB did not, and their specific functions remain unclear (29, 95).  The 
secondary structure of the HCV 3' UTR may also be important for replication, disruption 
of a stem-loop structure in the HCV 3' UTR in an infectious clone construct was viable 
in chimpanzees, although no infectious virus was produced viral RNA containing the 
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mutations were detectable at 2 and 5 weeks post inoculation suggesting a role for the 3' 
UTR in HCV genome stability (49).  Lanford et al. also demonstrated that a poly U-UC 
region deletion was not infectious.  It has been shown that PTB binds this poly U-UC 
region so it is possible that PTB binding may be necessary for replication in vivo. 
The importance of proteins binding to the 5' UTR and 3' UTR of other 
flaviviruses has also been studied, and it has been demonstrated for Japanese 
Encephalitis Virus that NSP3 and NSP5 bind to the 3' UTR.  Both are components of the 
replicase complex, but their exact role in replication is not known.  An RNA secondary 
structure of West Nile Virus’s 3' UTR has been shown to regulate viral RNA translation.  
A pseudoknot is formed within the 3' terminal stem-loop, and when this stem-loop is 
mutated or deleted in a West Nile virus replicon no viral proteins are detected (54). 
Picornavirus cis-acting sequences have also been extensively studied to 
determine if RNA conformation, host protein binding, or both influence steps of the 
virus life cycle.  See Figure 10.  It has been demonstrated in poliovirus that La, PTB and 
PCB bind the IRES of the 5' UTR (6).  Xenopus laevis oocytes injected with poliovirus 
genomic RNA and treated with anti-PCB antibodies showed a decrease in translation of 
polio RNA, demonstrating an in vivo necessity for PCB binding to the IRES of the 5' 
UTR.  It has also been demonstrated that the 5' UTR binds viral proteins 3AB, 3CD, and 
host proteins EF-1! and an unknown factor of 36kDa.  La has also been shown to bind 
to the 3' portion of the IRES and anti-La antibodies specifically decreased translation of 
poliovirus RNA (6).  Roles for the binding of 3CD and PCB have been demonstrated,  
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Figure 10.  IRES of the poliovirus genome and its associated proteins.  For the 
proteins whose binding region has been identified the protein is shown 
associating with the IRES in that region.  For those proteins, La, PTB, 
unknown, and EF-1alpha, whose binding sites have not been specifically 
identified lie near their binding region.
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and 3CD and PCB are thought to form a RNP complex at stem-loop B of stem-loop I 
cloverleaf (27).  When PCB binds to the stem loop B it enhances translation of viral 
RNA’s while 3CD binding decreased translation and promoted negative strand synthesis 
(27).  PCB has also been shown to enhance translation of hepatitis A RNA’s (31).  The 
data suggest that PCB and 3CD work against one another.  It is possible that PCB 
stabilizes the poliovirus RNA and keeps translation occurring and once 3CD is in a high 
enough concentration that it competes off PCB, either directly or by binding a second 
site causing a change in RNA conformation which then releases PCB, or allows another 
factor or set of factors to bind which cause the switch from translation to replication 
(27). 
Eukaryotic initiation factor 4B has also been shown to interact with the 
poliovirus IRES and is thought to help form the translation initiation complex at the 5' 
end of the poliovirus genome (71). eIF4E is part of the cap binding protein along with 
eIF4G and eIF4A, while eIF4F binds the 18S ribosomal subunit to the 5' end of the 
mRNA, or in the case of an infected cell the poliovirus genome.  eIF4B binds to the 18S 
ribosomal subunit and ribosome bound eIF4F and stimulates RNA helicase activity.  It 
has been demonstrated that eIF4B binds to domains V and VI of the poliovirus IRES, it 
forms ribosome initiation complex and was also found to bind to PTB (71). 
Proteins which have been shown to bind to the poliovirus 3' UTR are 3AB, 3CD 
and a 36kDa host protein; mutational analysis demonstrated that decreased binding of 
protein complexes also decreased replication, possibly through disrupting negative 
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strand synthesis (64).  To the contrary it has also been demonstrated that poliovirus that 
had its 3' UTR deleted still replicated, but not as well as wild type (99).   
Reverse genetics systems for coronaviruses. Recently Master’s lab developed targeted 
recombination, which is a technique that should allow the construction of mutant 
viruses.  Master’s lab has been successful in developing two targeted recombination 
systems; both take advantage of a temperature sensitive MHV A59 mutant, Albany 4 
(Alb4) and the DI B36.  Albany 4 has an 87 nucleotide deletion that results in a 
thermolabile, temperature sensitive phenotype.  The DI, B36, carries a wild type N gene 
that acts as a donor to repair the temperature sensitive phenotype and would also carry 
any mutation into the Alb4 genome that is present in DI B36.  Viruses are then selected 
against by heat treatment and those viruses that survive should be a recombinant 
carrying any mutation inserted.  The other targeted recombination system takes 
advantage of a cell line produced by Holmes’s lab (100).  Holmes’s lab introduced the 
feline aminopeptidase N gene into BHK cells so that the BHK cells express the feline 
aminopeptidase N gene, which is the receptor for Feline Infectious Peritonitis Virus 
(FIPV).  The BHK cells produce infectious virus to equal titer of the normal host cell 
(100).  Master’s lab developed a construct based upon B36 that grafts genes 3-6 onto 
B36’s gene 7.  Masters et. al then replaced the MHV spike protein (gene 3) with FIPV’s 
spike protein.  The construct pFM1 is transcribed and transfected into Alb4 infected L2 
cells carrying any mutation inserted into genes 4-7 with it.  Recombination takes place 
and virus carrying FIPV’s spike protein in an MHV backbone along with any inserted 
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mutations is produced.  Viruses are then selected by passage onto Holmes’s BHK’s to 
propagate recombinant virus (45). 
 Another approach to reverse genetic systems is cDNA infectious clones.  While 
many of these have been developed and used for other RNA viruses, the large genome 
size of coronaviruses hampered their development until recently.  For example infectious 
clones exist for equine arterivirus, Hepatitis C virus, mouse hepatitis virus, transmissible 
gastroenteritis virus, avian infectious bronchitis virus, human coronavirus 229E, West 
Nile Virus, poliovirus, classical swine fever virus, yellow fever virus, citrus tristeza 
virus, dengue virus, vesicular stomatitis virus, and others (15, 30, 49, 66, 80, 98, 107, 
108, 3, 8, 77, 82, 89, 102, 104).   
The first approach in construction of infectious cDNA clones is to engineer full-
length cDNA copies assembled from fragments into one plasmid with an RNA 
polymerase promoter, usually T7.  Plasmids carrying the clone are amplified, linearized, 
transcribed, and transfected into recipient cells that can support growth of the virus.  
This approach has been used for West Nile virus, dengue virus, citrus tristeza virus, 
hepatitis C virus, classical swine fever virus, and transmissible gastroenteritis virus (3, 
38, 49, 66, 82, 89).  The cells are then incubated and wild type virus is harvested.   
Another approach for infectious clones is to assemble cDNA fragments into a 
full-length clone either in plasmids or vaccinia virus constructs under a T7 promoter and 
transfect cDNA into T7 expressing recombinant vaccinia virus cells.  T7 vaccinia drives 
the transcription of the cDNA to produce infectious virus.  This approach has been used 
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for vesicular stomatitis virus, human coronavirus and infectious bronchitis virus (15, 98, 
104). 
For some infectious clones stability of the cDNA has been an issue, often 
deletions of necessary sequence result in a non-infectious cDNA clone (3, 30, 80).  
Stability issues lead to the third approach of propagating stable cDNA fragments of the 
virus, assemble the fragments by ligation and transcribe the assembled full-length 
cDNA. The full-length RNA is transfected into permissive cells, this approach has been 
used for yellow fever virus, transmissible gastroenteritis virus, and mouse hepatitis virus 
(80, 107, 108). 
 Enjuanes’s group developed the first infectious clone system for coronaviruses 
using the first approach (3).  They engineered the TGEV genome into a bacterial 
artificial chromosome with a cytomegalovirus immediate early promoter upstream to the 
viral coding region.  The BAC was then propagated in E. coli and purified.  BAC’s were 
then transfected into BHK cells and the cytomegalovirus promoter drove transcription of 
the viral genome and rescue of infectious TGEV particles from the BHK cells.  As 
mentioned previously there was a problem with stability while in E. coli, and deletions 
of gene 1 would result which did not allow virus to propagate.  To overcome the 
instability Enjuanes’s group inserted an artificial intron into several regions to stabilize 
the BAC, the intron was designed to be spliced from the TGEV RNA by the BHK 
nucleus and infectious TGEV can be recovered (30). 
 The other coronavirus systems are a variation of the second approach described 
and take advantage of vaccinia virus constructs which can hold up to 27 kb of non-
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vaccinia coding space (15).  IBV and human coronavirus 229E have been constructed as 
infectious clones using this approach (15, 98).  IBV is the first group 3 coronavirus 
constructed into an infectious cDNA clone.  The infectious clone was assembled from 3 
fragments into a vaccinia virus cDNA propagated, isolated, linearized, and then 
transfected into a vaccinia susceptible cell line that was infected with T7 expressing 
vaccinia.  IBV was recovered only when IBV N gene expression constructs were co-
transfected.  Human coronavirus 229E (HCoV-229E) was engineered in a similar 
fashion (98).  Portions of the HCoV 229E genome were assembled from 2 plasmids and 
a cDNA that was unstable as a plasmid construct into a vaccinia virus vector and grown.  
After this first construct was generated a third plasmid carrying the 5' UTR and ORF 1a 
was ligated in position, vaccinia was propagated and DNA was isolated from infected 
cells.  The HCoV-229E region of the vaccinia DNA was excised, in vitro transcribed and 
transfected into susceptible cells.  Infectious virus that could not be distinguished from 
parental virus, except for engineered markers, was isolated. 
 The third approach was used by Baric to generate coronavirus infectious clones 
for TGEV and MHV-A59 (107, 108).  Instead of trying to keep the genome together and 
propagated in E. coli, and hope there were no deletions of unstable regions, Baric 
decided to propagate smaller stable fragments of the genome in E. coli, use restriction 
enzymes to separate the region of interest, assemble the genome in order, transcribe and 
transfect into recipient cells that would support coronavirus growth (BHK’s).  TGEV 
was separated into 6 fragments that could be propagated in E. coli and MHV was 
separated into 7 fragments.  The fragments were generated based upon their stability; if a 
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plasmid was unstable portions of the fragments were rearranged until stable.  The 
fragments were engineered to have Bst XI, Esp 3I, and Bgl 1 sites that recognize specific 
DNA sequence and leave variable overhangs.  The variable overhangs were designed not 
to disrupt the reading frame of the MHV and TGEV genomes and provide specificity so 
that the fragments align in proper gene order.  The design of the overhangs gives 
specificity to the junction sites for an in vitro ligation step that joins the genome 
fragments in correct order without alteration of sequence.  To design appropriate ends 
for ligation some silent mutations had to be introduced in order to engineer the 
restriction enzyme sites.  After assembly of the fragments the cDNA is transcribed and 
transfected into permissive cells.  The infectious clones for TGEV and MHV constructed 
in this manner have produced progeny virus that are identical to wild type strains.  These 
constructs can then be used to generate mutant viruses that could not be produced using 
targeted recombination. 
Specific Aims 
 Mouse hepatitis virus contains a 3' UTR that has essential functions in the MHV 
lifecycle.  The purpose of this dissertation is to further define the 3' UTR’s 3' terminal 42 
nucleotide host protein binding elements role in the MHV lifecycle. 
 The specific aims were: 
1. Investigate the structural requirements of the protein-binding element in the 
3' terminal 42 nucleotides of the MHV 3' UTR. 
2. Determine the role of the 3' terminal 42 nucleotide host protein binding 
element in MHV replication. 
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3. Determine at which step(s) in the MHV-A59 lifecycle the 3' 42 nucleotide 
host protein binding element functions. 
Aim one was accomplished by developing mutants of the 3' 42 nucleotide host 
protein binding element that disrupted predicted base-pairing and to test the effects of 
the mutations on host protein binding using gel mobility shift-RNase T1 protection 
assays.  Compensatory mutations were developed that restored predicted wild type 
secondary structure and assayed by gel mobility shift-RNase T1 protection assays to 
determine if host protein binding was restored.  In an attempt to fulfill aim 2 the 
mutations were then engineered into a targeted recombination system using DI B36 and 
screened by sequencing in an attempt to produce a mutant virus.  Targeted 
recombination failed to produce a mutant virus, so DI replication assays were attempted 
to determine the role of the mutations in replication.  For 3 of the 6 mutants assayed DI 
B36 underwent recombination to restore wild type primary structure.  The other 3 
mutants failed to produce positive strand DI B36.  Semi-quantitative RT-PCR 
demonstrated that the DI B36 mutants produced complementary strand DI B36 at almost 
equivalent levels when compared to wild type DI B36.  The data suggests a role for host 
protein binding in the production of positive strand RNA, in addition to the requirement 
for the 3' terminal 55 nucleotides in complementary strand synthesis demonstrated 
previously (55).  
In order to accomplish Aim 3, the mutations developed in Aim 1were introduced 
into Baric’s cDNA infectious clone of MHV-A59 (108).  Currently seven mutant viruses 
are under construction.  When completed the mutant viruses will be used to determine 
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the role of the 3' 42 nucleotide host protein binding element in the MHV lifecycle.  The 
first step will be to sequence the 3' terminal 400 nucleotides of the virus to ensure the 
intended mutations are present, or determine what alternate sequence could be used for 
replication.  After sequencing, growth curves of the constructed virus will be performed 
to determine an overall effect on virus production using wild type MHV-A59 as a 
control.  To date two of the viruses have been constructed and sequence data is 
forthcoming. 
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CHAPTER II 
GENERATION OF THE 3' TERMINAL 42 NUCLEOTIDE HOST PROTEIN 
BINDING ELEMENT MUTANTS 
 
 
Introduction 
 
Previous work by Yu and Leibowitz demonstrated that the 3' UTR of the Mouse 
Hepatitis Virus (MHV) genome contained two host protein binding elements (109).  In 
Yu’s work and follow up work by Liu and Leibowitz the elements were defined as the 3' 
terminal 42 nucleotides and an upstream element consisting of nucleotides 154-129, 
within these elements is a conserved eleven nucleotide sequence UGARNGAAGUU 
(56, 109).  Replication assays using DIssE wild type and constructs containing mutations 
within the eleven nucleotide host protein binding motif resulted in restoration of the wild 
type sequence due to recombination with the helper virus (MHV-JHM), suggesting a 
role for the 11nt motif in replication.  Gel mobility shift RNase T1 protection assays of 
probes with the same mutations as DIssE showed a decrease in host protein binding 
when compared with wild type probe (56, 109). 
Other MHV replication studies implicate a role for RNA secondary structure in 
virus replication.  Hsue and Masters found a 68 nucleotide stem loop structure 
immediately downstream of the stop codon for mRNA 7 that was essential for 
replication (34).  Makino’s lab determined that secondary structure at the intergenic 
region played a role in transcription of MHV RNA’s (78).  RNA secondary structure has 
also been shown to be important for replication and translation of other RNA viruses 
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such as Hepatitis C, poliovirus, and yellow fever virus (1, 8, 9, 27-29, 43, 64, 71, 72, 75-
77, 86, 91, 94, 106). 
The goal of the current study was to determine if RNA secondary structure 
played a role in ribonucleoprotein (RNP) complex formation between host proteins and 
the 3' terminal 42nt element, as determined by gel mobility shift RNase T1 protection 
with mutant and wild type probes.  The initial development of mutant probes was based 
upon Yu and Leibowitz’s computer predicted secondary structure (109).  Computer 
modeling using Mfold version 3.0 was used to develop second site mutants that restore 
wild type secondary structure, yet maintain the initial primary structure mutants, and 
evaluate those mutants for RNP complex formation using gel mobility shift RNase T1 
protection assays. 
Materials and Methods 
Cells and lysates.  17CL-1 fibroblasts were maintained in DMEM supplemented with 
10% calf serum (HyClone Logan UT) with 2mM glutamine (Invitrogen Carlsbad, CA) at 
37ºC in a 5% CO2 environment.  Cells were collected by scraping 10 flasks of confluent 
17Cl-1 cells into 20-30ml of PBS and centrifuging at 1,000xg for 5 minutes.  Cell pellets 
were resuspended in 2.5ml of hypotonic buffer, consisting of 10mM HEPES (Sigma St. 
Louis, MO), 1.5mM MgCl2 (Sigma St. Louis, MO), 10mM KCl (Sigma St. Louis, MO), 
and 0.2mM PMSF (Sigma St. Louis, MO) and incubated on ice for 5 minutes.  The non-
ionic detergent NP40 (Sigma St. Louis, MO) was added to a final concentration of 0.5%, 
the cells were vortexed for 30 seconds, incubated on ice for 10 minutes, and then 
vortexed again for 30 seconds.  Lysates were centrifuged at 3,000xg for 10 minutes to  
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pellet cell nuclei; after centrifugation the supernatant was removed and glycerol was 
added to a final concentration of 5%.  Cell supernatants were then aliquoted into 40 "l 
portions and stored at -80ºC.   A portion of the lysate was set aside for protein 
quantitation using the Bio-Rad Protein Assay (Bio-Rad Hercules, CA). 
PCR and template isolation.  PCR was carried out using primers listed in Table 1.  
Primers were synthesized by Sigma Genosys (Sigma Genosys The Woodlands, TX).  
The reaction conditions were as follows: 14 cycles of 95ºC for 30 seconds, 55ºC for 60 
seconds, 72ºC for 60 seconds, 16 cycles of 95ºC for 30 seconds, 45ºC for 60 seconds 
72ºC for 60 seconds, followed by a fifteen-minute incubation at 72ºC.  PCR products 
were then purified by electrophoresis in a 1X TAE, 4% NuSeive GTG agarose (FMC  
Rockland ME) gel; the amplified fragment was located by ethidium bromide (Sigma St. 
Louis, MO) staining and excised from the gel with a scalpel and recovered using the 
Qiagen Qiaquick Gel Extraction Kit (Qiagen Valencia, CA).  
Transcription of RNA probes.  Transcription was conducted under the following 
conditions: 20 units T7 RNA polymerase (Promega Madison, WI), 14 U RNasin 
(Promega Madison, WI), 1.2 mM NTP’s, 1X T7 Transcription Buffer (Promega 
Madison, WI), 250 "Ci !32P-UTP (ICN Irvine, CA), 0.08mg/ml acetylated BSA 
(Promega Madison, WI), 8mM DTT (Promega Madison, WI), 200ng DNA template, and 
brought to a final volume of 50 "l using diethyl pyrocarbonate (depc) (Sigma St. Louis, 
MO) treated water.  Reactions were incubated at 37ºC for 1 hour and additional reaction 
mix of NTP’s, buffer, DTT, BSA, and enzyme was added for one additional hour.  The 
samples were then treated with 1 unit RQ1 DNase (Promega Madison, WI) for 15 
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minutes at 37ºC.  RNA’s were phenol: chloroform: isoamyl (25:24:1) extracted twice, 
chloroform extracted twice, then loaded on a Microcon 10 centrifugal filter device 
(Millipore Bedford MA) centrifuged for 30 minutes at 14,000xg, inverted and 
centrifuged at 900xg for 3 minutes.  Probes were quantitated based upon incorporation 
of !32P-UTP, and 1.4 picomoles of labeled RNA was used for each binding reaction.  
Unlabelled wild type probe was prepared in the same manner as labeled probe and 
quantitated based on spectrophotometry at O.D.260, yeast tRNA was obtained from 
Sigma (Sigma St. Louis, MO) proteinase K treated, phenol:chloroform extracted, 
chloroform extracted, ethanol precipitated and resuspended in depc (Sigma St. Louis, 
MO) treated water to appropriate concentrations. 
Gel mobility shift RNase T1 protection assays.  The gel mobility shift RNase T1 
protection assays were carried out as described by Yu and Leibowitz (109).  Seven and 
one-half micrograms of protein was used for each reaction.  Reactions were carried out 
at 22ºC for 20 minutes in 1X reaction buffer consisting of 100mM KCl (Sigma St. Louis, 
MO), 10mM Tris (Invitrogen Carlsbad, CA) pH 7.6, 5mM MgCl2 (Sigma St. Louis, 
MO), 1mM DTT (Sigma St. Louis, MO), 500ng Poly (I)-(C) (Boehringer Manheim 
Indianopolis, IN), 10 "g Heparin (Sigma St. Louis, MO), and 1.4 pmoles of radiolabeled 
probe in a final volume of 20 "l.  After a 20 minute incubation, 0.006125 units of RNase 
T1 (Calbiochem -Novabiochem San Diego, CA) per 1.4 pmole of RNA was added to 
each reaction and incubated an additional 20 minutes at 22ºC.  Reactions with unlabeled 
wild type competitor and non-specific tRNA competitor at 10, 25, 50, 100X molar 
concentration were carried out in parallel.  The complete reaction was loaded onto a 1X 
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TBE, 6% nondenaturing polyacrylamide gel and electrophoresed for 4.5 hours.  Gels 
were transferred to Whatman 3CHR paper (Whatman Maidstone, UK) and dried at 80ºC 
under vacuum for 3 hours then exposed to Kodak Biomax MS film (Kodak Rochester, 
NY) and quantitated with a phosphoimager (Amersham Pharmacia Piscataway NJ).  Six 
gel shift assays of each mutant were used to generate an average binding efficiency, with 
wild type always set to 100%. 
Computer models. The Mfold RNA version 3.0 folding algorithm available at 
http://www.ibc.wustl.edu/~zuker/rna/node3.html was used to predict secondary structure 
(112).  The following parameters were used for all secondary structure modeling: no 
folding constraints, RNA sequence =linear, temperature fixed by the program at 37ºC, 
ionic conditions fixed by the program at 1M NaCl with no divalent cations, percent 
suboptimatility = 5, upper band = 50, default = window, maximum distance between 
paired bases set, output at high resolution, format = bases, base number frequency = 
default, structure rotation angle = 0, and structure annotation by p-num. 
UV cross-linking. Gel mobility shift RNase T1 protection assays to form RNP 
complexes were carried out as above with the following modifications.  After the RNase 
T1 digestion step the reactions were exposed to UV light at 254nm in a Hoefer UVC 500 
for 30 minutes in an acrylic block chilled to -20ºC at least 3 hours prior to use.  10 units 
of RNase A (Sigma St. Louis, MO) was added to each cross-linked reaction and 
incubated at 37ºC for 30 minutes.  The samples were then incubated at 100ºC in 2X 
sample buffer consisting of 50mM Tris Cl (Invitrogen Carlsbad, CA) pH 6.8, 100mM 
DTT (Sigma St. Louis, MO), 2% SDS (Sigma St. Louis, MO) 0.1% bromophenol blue 
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(Sigma St. Louis, MO) and 10% Glycerol (EM Science Gibbstown, NJ) for 3 minutes 
and electrophoresed on a 10% SDS-PAGE gel for 5 hours, dried and exposed to Kodak 
Biomax MS film (Kodak Rochester, NY). 
Results 
Gel mobility shift RNase T1 protection assays and RNA secondary structure 
predictions.  Work by Yu and Leibowitz defined two host protein-binding elements 
within the 3' UTR of the MHV genome (56, 109, 110).  The two elements are located at 
positions 154-129 and the 3' terminal 42 nucleotides as defined by Yu using gel mobility 
shift RNase T1 protection assays.  The 3' 42nt element was the smallest probe that 
formed ribonucleoprotein complexes and sequence analysis of the two elements revealed 
a shared 11nt motif, UGARNGAAGUU.  Secondary structure analysis using Mfold 2.0 
indicated that the 3' terminal 42nt host protein binding element formed a small stem loop 
structure.  The nucleotides that compose the 11nt motif form part of the right hand 
portion of a stem in a bulged stem loop predicted by Yu and Leibowitz (109).  The 11nt 
motif was targeted for mutagenesis by replacing the wild type nucleotides with 
nucleotides that would not base pair with the wild type nucleotide’s pairing partner in 
Yu’s predicted structure.  For example mutant MT1A contains a 36U to A mutation, 
36U’s pairing partner was 15A and the introduction of an A residue should prevent that 
pairing.  Yu’s structure also predicts that the 3' terminal 10 nucleotides are single 
stranded so a mutant deleting those 10 nucleotides was developed, MD10 was designed 
to test if all that was required was the stem loop formed by the 11nt motif and its pairing 
partners. 
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Figure  11. Secondary structure models for the initial set of mutants.  Predictions were 
generated using the Mfold 3.0 RNA folding algorithm.  The mutant nucleotides are 
circled The color of each nucleotide and base pairing indicate the likelihood that the 
given nucleotide is involved in a particular secondary structure.  Red indicates that the 
structure is likely where blues and blacks indicate that a particular structure for a given 
nucleotide is less likely.
WTA MT1A MT2A
MT3C MT5A MD10
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The more recent version of Mfold (version 3.0) indicated that the secondary 
structure would be slightly different than that predicted by Mfold 2.0.  Mfold 3.0 
indicates that nucleotides 27-42 are single stranded with the remaining nucleotides 
forming a bulged stem-loop structure.  See Figure 11.  The loop of the wild type 
predicted structure involves nucleotides 12-15 with nucleotides 10 and 11 pairing with 
nucleotides17 and 16, the bulge is composed of nucleotides 6-9 and 18-22.  Nucleotides 
2-5 form a portion of a stem by pairing with nucleotides 26-23 and nucleotide 1 is 
unpaired.  Secondary structure models generated with Mfold 3.0 of probes MT3C, 
MT5A, and MD10 indicate different secondary structures may have formed.  MT3C’s 
most thermodynamically favored model indicates that the nucleotides 36-42 are single 
stranded with 2 stem-loops forming.  The first stem-loop involves nucleotides 29-24 as 
the loop and nucleotides 30-35 pairing with 18-24 as the stem, the second stem-loop is 
formed by nucleotides 10,11 and 16, 17 with 12-15 still maintaining a stem-loop 
structure as in wild type predictions.  When MT5A is analyzed with Mfold 3.0 it takes 
on a different structure, nucleotides 1-6 are single stranded as are nucleotides 36-42; a 
bulged stem loop is formed by the remaining nucleotides with nucleotides 10, 11 and 30, 
31, 32 forming the bulge, nucleotides 17-24 compose the loop and the remaining 
nucleotides form the stem portions of the predicted structure.  Probe MD10 takes on a 
simple stem-loop structure with nucleotides 11 and 29-42 single stranded, nucleotides 
17-24 forming the loop, and the stem formed by 11-16 pairing with 25-29.  See Figure 
11. 
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Table 2. Summary of MT binding data 
Probe Sequence* % 
Binding 
Std 
Dev 
Predicted 
Effect on 2º 
Structure 
 
Wild type 5' AGUAAAUGAAUGAAGUUGAUC 
   AUGGCCAAUUGGAAGAAUCAC 
 
100 N/A N/A 
MT1A 5' AGUAAAaGAAUGAAGUUGAUC 
    AUGGCCAAUUGGAAGAAUCAC 
 
68.5 11.3 NONE 
MT2A 5' AGUAAAacAAUGAAGUUGAUC 
   AUGGCCAAUUGGAAGAAUCAC 
 
64 21.7 NONE 
MT3C 5' AGUAAAacuAUGAAGUUGAUC 
   AUGGCCAAUUGGAAGAAUCAC 
 
6.3 6.1 DISRUPTS 
MT5A 5' AGUAAAacuuaGAAGUUGAUC 
   AUGGCCAAUUGGAAGAAUCAC 
 
25.2 5.5 DISRUPTS 
MD10 5' AGUAAAUGAAUGAAGUUGAUC 
    AUGGCCAAUUG 
44.1 2.5 DISRUPTS 
  
* lower case nucleotides indicate mutations 
   
 
 52 
The 5 mutant probes generated, except for MD10, carried their mutations within 
the 11nt motif located from position 26 to 36.  Mutant MT1A carried a single nucleotide 
mutation of 36U to A; it maintained wild type secondary structure and bound 68.5% as 
well as wild type probe.  Mutant probe MT2A carried MT1A’s mutation and an 
additional mutation of 35G to C it also maintained wild type secondary structure and 
bound 64% relative to wild type sequence.  Probe MT3C formed RNP complex 6.3% as 
well as wild type probe, it carries 3 mutations 34A to U, 35G to C, 36U to A and alters 
its predicted secondary structure.  Mutant probe MT5A had mutations in 5 positions 
within the 11nt motif.  The mutations were the same mutations as MT3C with two 
additional mutations at positions 33A to U and 32U to A.  MT5A’s secondary structure 
is altered as well, but its ability to form RNP complexes is elevated when compared to 
MT3C at 25.2% of wild type.  Probe MD10 was a 3' terminal 10 nucleotide deletion, and 
with this mutation the 11nt motif’s primary sequence was intact and RNP complex 
formation efficiency was reduced to 44.1% of wild type.  See Table 2. 
In order to determine a role for secondary structure in host protein binding Mfold 
3.0 was used to develop second site mutations that were predicted to restore wild type 
secondary structure and test their effects on host protein binding.  Mutant MT3C had the 
greatest amount of alteration when compared to wild type and had the least amount of 
binding activity according to the gel shift assay data.  A second site mutant was 
developed for MT3C using Mfold 3.0, and mutant nucleotides were introduced into the 
MT3C sequence starting at the 3' end and evaluated based upon the secondary structure 
models generated.  When nucleotide 19 was converted from a G to a C residue Mfold  
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Table 3. Summary of MT3C mutants binding activity 
Probe Sequence* % 
Binding 
Std 
Dev 
Predicted  
Effect on  
2º Structure 
 
Wild type 5' AGUAAAUGAAUGAAGUUGAUC 
    AUGGCCAAUUGGAAGAAUCAC 
 
100 N/A N/A 
MT3C 5' AGUAAAacuAUGAAGUUGAUC 
      AUGGCCAAUUGGAAGAAUCAC 
 
6.3 6.1 DISRUPTS 
M24C 5' AGUAAAacuAUGAAGUUGAUC 
     AUcGCCAAUUGGAAGAAUCAC 
 
74.1 8.6 RESTORES 
24C 5' AGUAAAUGAAUGAAGUUGAUC 
  AUcGCCAAUUGGAAGAAUCAC 
73.5 25.4 NONE 
  
*lower case nucleotides indicate mutations 
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predicted that it would reform the wild type secondary structure. Based upon Mfold 
predictions probe 24C was generated and it carries the 19 G to C mutation, maintains 
wild type secondary structure and has a relative binding efficiency of 73.5% when 
compared to wild type probe.  Probe M24C carries the mutation of MT3C (34U, 35C, 
36A versus wild type of 34A, 35G, 36U) and the additional nucleotide 19 G to C 
mutation.   Mfold predicts that M24C takes on the same conformation as wild type and 
binding efficiency is near equal to the 24C probe at 74.1% of wild type.  See Figure 12 
and Table 3.  These data indicate that wild type secondary structure may play a role in 
the ability of the 3' terminal 42nt host protein-binding element to bind to host proteins.  
A similar attempt was made to restore the wild type secondary structure of MT5A but 
second site mutants of MT5A that restored wild type secondary structure by introducing 
additional single nucleotide mutations to the sequence could not be identified. 
Since the updated version of Mfold predicts a different secondary structure for 
the wild type sequence more mutations were made in the region of base pairing between 
nucleotides 23-26 and nucleotides 2-5. Nucleotide 26U is the last nucleotide composing 
the 11nt motif. Nucleotides 23U, 24A, 25G, 26U were replaced with 23A, 24U, 25C, 
26A to make the probe ATW5'. ATW5' disrupts secondary structure with the only base 
pairing occurring between nucleotides 10-11 and 16-17 with a small loop formed by 12-
15.  See Figure 13.  ATW5' binds 7.2% as well as wild type sequence.  Probe ATW3' 
was generated by converting 2A to U, 3C to G, 4U to A, 5A to U it disrupts secondary 
structure slightly and binds 4 times as well as wild type sequence.  The double mutant, 
ATW, contains ATW5' and ATW3' mutations, restores wild type secondary structure 
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Table 4. Summary of ATW mutants binding activity 
Probe Sequence* % 
Binding 
Std 
Dev 
Predicted 
Effect on  
2º Structure 
 
Wild type 5’ AGUAAAUGAAUGAAGUUGAUC 
AUGGCCAAUUGGAAGAAUCAC 
 
100 N/A N/A 
ATW5’ 5’ AGUAAAUGAAUGAAGUacuaC 
    AUGGCCAAUUGGAAGAAUCAC 
 
7.2 8.7 DISRUPTS 
ATW3’ 5’ AGUAAAUGAAUGAAGUUGAUC 
AUGGCCAAUUGGAAGAuaguC 
 
400 
 
84.4 DISRUPTS 
ATW 5’ AGUAAAUGAAUGAAGUacuaC 
AUGGCCAAUUGGAAGAuaguC 
 
185.8 34.7 RESTORES 
 *lower case nucleotides indicate mutations    
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and binds 1.85 times as well as wild type sequence.  See Figure 13 and Table 4.  The 
increase in binding for mutants ATW and ATW3' was surprising and it reinforces the 
concept that both primary and secondary structure play a role in host protein binding to 
the 3' terminal 42nt host protein binding element. 
Wild type, MT1A, MT2A, MT3C, ATW, ATW5', and ATW3' were all predicted 
to base pair between nucleotides 10-11 and 16-17.  Mutations at positions 10-11 and 16-
17 were explored using Mfold 3.0 but no compensatory mutations could be identified.  
Since the base pairing is conserved in mutants with little binding activity as well as those 
with increased binding activity it could be concluded that this region of secondary 
structure is not sufficient for host protein binding. 
UV cross-linking.  Since two of the mutant probes had an increase in binding activity it 
was prudent to determine if the mutant RNA probes were binding to the same proteins as 
the wild type probe.  UV cross-linking was carried out by using our standard gel shift 
assay followed by a 30 minute UV cross-link step and RNase A digestion.  The reactions 
were electrophoresed on 10% SDS-PAGE.  The gel was dried and exposed to film.  
The proteins that bound mutant and wild type probes appear to have the same 
molecular weight and no additional proteins were resolved.  The amount of labeled 
protein appeared to parallel the signal obtained in gel mobility shift RNase T1 protection 
assays.  In this context UV cross-linking is not quantitative because the molar ratios of 
the proteins involved in the complex is unknown and cross-linking of the RNA to the 
proteins involved in the RNP complex will vary, so measuring relative binding 
efficiency through this method was not attempted.  However, the probes that had  
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tremendous decreases in protein binding activity, ATW5' and MT3C, also had decreased 
amounts of cross-linked protein; probes ATW and ATW3' appeared to cross-link more 
protein using this assay.  See Figure 14. 
Conclusions 
The goal of the study was to determine if RNA secondary structure was 
important in the formation of RNP complexes composed of host proteins and the 
previously identified 3' 42 nucleotide host protein binding element of the MHV 3' UTR.  
A combination of gel mobility shift RNase T1 protection assay and computer modeling 
with the Mfold 3.0 algorithm was used to accomplish the goal.  Probes were generated 
that were predicted to disrupt secondary structure of the 3' 42 nucleotide host protein 
binding element as predicted by Yu and Leibowitz and assayed for binding to a complex 
of host proteins.  The secondary structure of the mutant probes was also analyzed by 
computer modeling.  Probes MT1A and MT2A maintained wild type secondary structure 
and had modestly decreased RNP complex formation; this suggests that RNA primary 
sequence is important for protein binding.  Probes MT3C, MT5A, and MD10 all had 
disruption of their secondary structure and a greater decrease in host protein binding.  
The decrease in binding alone does not support a role for secondary structure, so Mfold 
was used to generate compensatory mutations that would restore secondary structure and 
maintain the original deleterious mutations. Gel mobility shift RNase T1 protection 
assays were carried out using the second site mutation alone and in combination with the 
original mutations.  Probe M24C was designed, it contained the MT3C mutations and an 
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additional compensatory mutation that restored computer predicted wild type secondary 
structure, as well as host protein binding activity. 
The MT3C, M24C and 24C predicted secondary structure and binding data 
suggest that primary sequence does play a role in host protein binding; the data also 
support the concept that secondary structure is important for protein binding.  When the 
additional G to C mutation at position 19 is introduced in probe M24C predicted wild 
type secondary structure is restored and relative binding of the probe increases from 
6.3% to 74%.  When the G to C mutation is present in otherwise wild type probe its 
binding efficiency is 73.5% of wild type and its secondary structure is predicted to match 
wild type.  The increase in binding activity in a probe carrying deleterious mutations in 
conjunction with a second site mutation that restores predicted wild type secondary 
structure supports a role for RNA conformation in formation of RNP complexes 
involving host proteins. 
Mutants MT1A, MT2A, MT3C, MT5A, and MD10 were all designed based upon 
predicted secondary structure of the 3' 42 nucleotide host protein binding element using 
Mfold 2.0 that was available to Yu and Leibowitz (109).  The updated Mfold  (version 
3.0) predicts a different secondary structure for the wild type 3' 42 nucleotides.   Probes 
ATW, ATW3', and ATW5' were developed based upon the current Mfold software that 
predicts a small stem involving 8 nucleotides (2-5 pairing with 26-23) for the wild type 
sequence.  Probes ATW3' and ATW5' were designed to disrupt the small stem base 
pairing, while probe ATW was designed to restore protein binding and secondary 
structure.  The data generated with the ATW, ATW3', and ATW5' probes supports the 
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idea that primary sequence is important for host protein binding, it also argues that 
secondary structure will affect host protein binding. 
The data generated from the gel shift assays and computer predictions also backs 
up the idea that the 11nt motif present in both binding elements is important for host 
protein binding.  The data generated with the MT1A, MT2A, MT5A, MT3C, M24C, and 
24C probes demonstrate that primary sequence is not the only factor involved in host 
protein binding.  The MT1A mutation did not disrupt secondary structure, but decreased 
binding of host proteins to the probe by 31.5%.  The addition of a second mutation 
(MT2A), also in the 11nt motif dropped binding 36% when compared to wild type probe 
although it maintained wild type secondary structure.  The MT3C mutations were the 
most informative.  MT3C decimated host protein binding to almost zero, 6.3%.  When a 
second mutation was introduced which restored wild type secondary structure but 
maintained the deleterious MT3C mutation binding increased to 74.1% of wild type, the 
second site mutation alone had a binding efficiency 73.5% of that of wild type probe.  
The decreased binding by the double mutant M24C supports the role of the 11nt motif in 
host protein binding.  If primary structure were the only factor involved in host protein 
binding then one would expect the second site mutant to have a similar binding 
efficiency as the original MT3C mutant instead of an increase as was observed.  If 
secondary structure was all that was required for binding the restoration of wild type 
secondary structure would restore host protein binding activity back to wild type level.  
It is possible that the second site mutant would bind other proteins that give the same 
appearance in the gel shift assay, but the UV cross-linking experiment rules this out as 
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the proteins that are cross-linked had the same electrophoretic mobilities with wild type, 
ATW3', and ATW probes. 
When Mfold predicted secondary structure models were compared to data 
generated by enzymatic digestion of an RNA molecule composed of the 3' terminal 166 
nucleotides, the data indicate there are similarities between the Mfold model and 
biochemical data suggesting the data are accurate for many regions of the RNA (57).  
Technical difficulties kept Liu et al. from obtaining data on the 3' terminal 12 
nucleotides.  Analyzing Liu’s data by comparing enzymatic probing to the model 
generated by Mfold for the 3' terminal 166 nucleotides, indicates that nucleotides 42-12 
only agree on conformation in 13 of 26 positions of the 31 common nucleotides with 5 
ambiguous nucleotides.  When the 11nt motif is examined it is found that 4 of the 
nucleotides agree on conformation between enzymatic probing data and computer 
predicted models with 3 out of 11 remaining are ambiguous based upon the digestion 
data.  Liu’s data upholds the notion that computer predicted models do not always 
accurately reflect true secondary structure, it must also be noted that this study and Liu’s 
study only analyze a miniscule portion of the MHV genome and that all nucleotides 
examined may take on a different secondary structure when considered in the context of 
the MHV genome. 
When the predicted secondary structure for the 31 common nucleotides is 
analyzed on whether or not a particular nucleotide’s conformation matches between 
digestion and modeling data we found that 26 could be evaluated and 5 were ambiguous.  
Enzymatic digestion data only provides information only on whether or not a given  
64
N
uc
le
ot
id
e
S
eq
ue
nc
e
D
ig
es
tio
n 
16
6
W
T
A
 
42
A
S
S
D
S
S
S
41
G
S
S
D
S
S
S
40
U
S
S
D
S
S
S
39
A
S
S
S
S
S
S
38
A
S
S
S
S
S
S
37
A
S
S
S
S
S
S
36
U
E
E
E
35
G
S
S
S
S
S
S
34
A
S
S
S
S
S
S
33
A
S
S
D
S
S
S
32
U
E
E
E
31
G
S
S
D
S
S
S
30
A
S
S
D
S
S
S
29
A
S
S
S
S
S
S
28
G
S
S
S
S
D
S
27
U
D
S
S
S
D
S
26
U
E
E
E
25
G
S
S
S
S
S
S
24
A
S
S
S
S
S
S
23
U
D
S
D
S
D
S
22
C
E
E
E
21
A
E
E
E
20
U
S
S
D
S
S
S
19
G
S
S
S
S
S
S
18
G
S
S
S
S
S
S
17
C
D
S
S
S
D
S
16
C
D
S
S
S
D
S
15
A
D
S
S
S
D
S
14
A
S
S
D
S
S
S
13
U
D
S
D
S
S
S
Fi
g
u
re
 1
5.
  
Th
e 
ch
ar
t 
at
 t
h
e 
le
ft
 in
d
ic
at
es
 t
h
e 
m
at
ch
es
 b
et
w
ee
n
 w
ild
 t
yp
e 
co
m
p
u
te
r 
p
re
d
ic
ti
o
n
s 
o
f 
th
e 
3'
 t
er
m
in
al
 1
66
 n
u
cl
eo
ti
d
e 
m
o
d
el
 
an
d
 t
h
e 
3'
 4
2 
n
u
cl
eo
ti
d
e 
m
o
d
el
 w
h
en
 c
o
m
p
ar
ed
 w
it
h
 d
ig
es
ti
o
n
 d
at
a.
  T
h
e 
p
re
d
ic
te
d
 s
ec
o
n
d
ar
y 
st
ru
ct
u
re
 m
o
d
el
 h
as
 b
ee
n
 u
p
d
at
e 
to
 r
ef
le
ct
 
th
e 
si
m
ila
ri
ti
es
 in
 s
ec
o
n
d
ar
y 
st
ru
ct
u
re
 b
et
w
ee
n
 t
h
e 
3'
 t
er
m
in
al
 4
2 
n
u
cl
eo
ti
d
es
 a
n
d
 th
e 
d
ig
es
ti
o
n
 d
at
a.
  
 65 
nucleotide is single or double stranded, it does not give potential base pairing partners. 
Wild type and mutant Mfold predictions that match wild type predicted structure agreed 
with digestion data on conformation for 23 of 26 nucleotides.  The data analysis allows 
us to modify the model proposed by Liu et. al.(57).  See Figure 15.   
Mutant MT3C matched enzymatic probing for 16 of the 31 nucleotides that could 
be compared, MT5A matched with 22 nucleotides, MD10 matched 24 positions, ATW3' 
which bound four fold of wild type probe matched in 25 positions, and ATW5' matched 
in 26 positions, but bound 7.2% as well as wild type probe.  The same analysis focusing 
only on the 11 nt motif indicates that wild type probe, probes with secondary structures 
similar to wild type, ATW3', and ATW5' all match the digestion data exactly.  MT5A 
matched in 4 positions, MT3C in 3 positions, and MD10 matched in 8 positions. 
The data suggests that conformation of individual nucleotides is not the 
determining factor in host protein binding.  It is possible, since the RNP complex is 
composed of four different proteins in unknown molar ratios, that primary sequence 
initiates binding of the first protein or complex causing a conformational change which 
allows binding of subsequent proteins or protein complexes.  This may explain the 
disparity of ATW3' and ATW5', ATW3' bound four fold as well as wild type probe and 
the predicted secondary structure matches digestion data well, whereas ATW5' barely 
formed RNP complexes and matches the digestion data better than ATW3'.  It is possible 
that the primary sequence of each is necessary to establish the initial protein binding 
which then leads to recruitment of the other proteins. ATW5' does not have the initial 
proper sequence or proper secondary structure.  It is also conceivable that ATW5' has the 
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proper initial signal (the 11nt motif) but the primary and secondary structure of the 
remaining nucleotides is substantially altered and does not allow for binding of the initial 
protein complex.  Alternatively ATW3' has the correct initial signal (either primary or 
secondary structure) and takes on a different conformation that allows binding of 
additional protein complexes giving it a higher relative score in our binding assays. 
The data support a role for secondary structure in host protein binding to the 3' 
42 nucleotide host protein binding element.  In order to investigate an in vivo role for 
host protein binding it would be necessary to introduce the mutations generated here into 
a DI construct or into a whole virus. 
 67 
CHAPTER III 
 
TARGETED RECOMBINATION OF THE MHV 3' 42 HOST PROTEIN 
BINDING ELEMENT MUTANTS 
 
 
Introduction 
 The purpose of this project was to deduce a role for the MHV 3' 42 host protein 
binding element in the MHV lifecycle.  As discussed in Chapter II a role for RNA 
secondary structure has been proposed as a factor for binding of host proteins to the 
MHV 3' UTR, but the function of proteins binding to the 3' 42 nucleotide host protein 
binding element remains unknown.  Previously, a study by Lin and Lai demonstrated 
that the 3' terminal 55 nucleotides are necessary for negative strand synthesis, but their 
study used CAT reporter assay constructs in an MHV backbone which may not represent 
a true function for the 3' terminal 55 nucleotides (55). Using selected 3' 42 nucleotide 
host protein binding element mutants developed in Chapter II we attempted to employ 
targeted recombination to determine the role of host protein in the MHV life cycle. 
 Masters developed the targeted recombination technique, which allows for the 
introduction of mutations into the mRNA 7 region of the MHV genome.  Masters 
developed a defective interfering RNA, B36, that carries the entire MHV mRNA 7 
(encoding the nucleocapsid protein) plus the 5' UTR, and a small segment of VSV G 
protein (42, 63).   The temperature sensitive A59 mutant Alb4, which has an 87 
nucleotide deletion in the nucleocapsid reading frame of mRNA 7, serves as a recipient 
for B36 and any mutations it may carry.  Alb4 is thermolabile at 40°C, which allows for 
selection against parental Alb4 when attempting targeted recombination.  Alb4’s small 
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plaque phenotype at 39°C, and a wild type plaque size at 34°C also provides a further 
selection tool to ensure that a plaque purified virus is most likely a recombinant virus.  
When recombination occurs between B36 and Alb4, the wild type A59 sequence is 
restored in Alb4 and the resulting recombinant virus is no longer thermolabile or 
temperature sensitive and will form large plaques at 39°C (63).  
The plan was to introduce selected mutations developed in Chapter II into B36 
and introduce DI B36 into Alb4 infected cells, select by thermolability, isolate individual 
recombinants by plaque dilution, screen by RT-PCR for restoration of the 87 nucleotide 
deletion, and sequence isolated positive strand RNA.  Of the 87 isolated viruses 
screened, 59 were Alb4 and 28 were recombinants.  Of those 28 recombinants all 
contained the wild type sequence regardless of the mutation introduced into B36.  
Materials and Methods 
Cells and virus.  17Cl-1 cells, a spontaneously transformed NIH 3T3 fibroblast cell line, 
were maintained at 37°C and 5% CO2 in DMEM (Invitrogen Carlsbad, CA) 
supplemented with 10% calf serum (HyClone, Logan UT).  L2 cells for plaque 
purification were maintained at 37°C and 3% CO2 in DMEM (Invitrogen Carlsbad, CA) 
supplemented with 10% calf serum (HyClone, Logan UT).  L2’s for targeted 
recombination were adapted to grow in suspension; maintained at 37°C and 3% CO2 in 
SMEM (Invitrogen Carlsbad, CA) supplemented with 10% calf serum (HyClone, Logan 
UT).  Alb4 virus was generously provided by Dr. Paul S. Masters and a stock was grown 
for experimental use (42).  Seven T-150 flasks of 17Cl-1 cells that were 70% confluent 
were infected at an M.O.I. of 0.01 at 34ºC until syncytia encompassed greater than 90%  
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of the cell monolayer, 2-3 days post infection.  The virus stock was frozen at -80°C then 
thawed at room temperature and refrozen.  The freeze thaw cycle was repeated twice.  
After freeze thaw virus stock was sonicated on ice for 3 pulses of 30 seconds at 30% 
power in a cup probe using a Heat Systems Sonicators Ultrasonic Processor XL (Heat 
Systems Sonicators Farmingdale, NY), and centrifuged at 2,500xg at 4°C for fifteen 
minutes.  The supernatant was removed and stored at -80°C until use in targeted 
recombination experiments, a small aliquot was set aside for determining virus titer.  
Virus titer was determined by 10 fold serial dilution of the virus stock on L2 cells 
overlayed with 0.8% agarose containing DME 2 for 2 days.  Plaque assays were fixed 
and stained with crystal violet in 80% methanol, 20% water. 
Site directed mutagenesis and pB36 mutant construction.  Dr. Paul S. Masters kindly 
provided the plasmid pB36.  To ensure that only mutations in the 3' 42 host protein 
binding element were introduced into pB36 a subcloning strategy to create a 
mutagenesis template was adapted.  See Figure 16.  B36 contains a Hind III site directly 
downstream of the poly (A) tail, and a Sac I site 178 nucleotides upstream of the Hind 
III site, this fragment was chosen as the mutagenesis template.  Primers B36SacI and 
B36HindIII were used to generate a PCR product for TA cloning using Invitrogen’s 2.1 
TA cloning kit (Invitrogen Carlsbad, CA).  PCR products were generated by 13 cycles of 
95ºC for 60 seconds, 50ºC for 30 sec, 72ºC for 90sec, then 16 cycles of 95ºC for 30 
seconds, 55ºC for 30 seconds, 70ºC for 60 seconds, then 17 cycles of 95ºC for 30 
seconds, 70ºC for 60 seconds followed by a 15 minute extension at 72ºC, using Taq 
polymerase and its appropriate buffers from Invitrogen Carlsbad, CA (Invitrogen 
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Figure 16. Overview of pB36 mutagenesis.
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Carlsbad, CA), 200!M dNTP’s (Amersham Pharmacia Piscataway, NJ) and 2 ng of 
pB36 template and 200nM primers. 
The resulting plasmid 2-1 carries the Sac I-Hind III fragment from pB36 and was 
used as a template for mutagenesis.  The mutants MT2A, MT3C, M24C, ATW, ATW5', 
and ATW3' mutations were introduced into plasmid 2-1 using the QuickChange Site 
Directed Mutagenesis kit (Stratagene La Jolla, CA) with primers listed in Table 4.  After 
carrying out the procedure for mutagenesis, potential mutant 2-1 plasmids were screened 
for their intended mutations by sequencing using the T7 primer from the Gene 
Technologies Lab at Texas A&M University Department of Biology.  Sequences were 
resolved on ABI 377 or 373 sequencing machines (ABI Foster City, CA).  Plasmids 
containing the desired mutant were used for subcloning back into pB36. 
The restriction enzymes Sac I and Hind III (Invitrogen Carlsbad, CA) were used 
to excise the 178 bp fragment that contains the 3'42 nucleotide host protein binding 
element from mutated plasmid 2-1 for subcloning into pB36.  Ten micrograms of mutant 
2-1 was digested and 5 !g of wild type pB36 was also cut for receipt of the mutant 
fragment using Sac I (Promega Madison, WI) and Hind III (Invitrogen Carlsbad, CA).  
The digested products were then gel purified using the Qiaquick Gel Extraction kit 
(Qiagen Valencia, CA).  Ligations were carried out using T4 DNA ligase and 
Invitrogen’s recommended procedure (Invitrogen Carlsbad, CA).  20 !l reactions were 
assembled using the Sac I-Hind III digested pB36 fragment and Sac I-Hind III digested 
2-1 mutant fragment and incubated at 24°C for 1 hour and then transformed into Top10F 
cells (Invitrogen Carlsbad, CA).  Potential pB36 mutants were selected and sequenced 
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using primer 5666 (5'GTAGTGCCAGATGGGTTA) (Sigma Genosys The Woodlands 
TX); colonies containing the desired mutation were amplified and glycerated stocks 
were maintained.  Plasmid pB36 was purified using the Midi Prep Plasmid Purification 
Kit (Qiagen Valencia, CA). 
In vitro transcription.  To generate DI RNA’s B36 mutants were linearilized using Nsi 
I (New England BioLabs Beverly, MA) and gel purified.  200ng of template was used in 
each reaction mix which consists of: 1X transcription buffer (Promega Madison, WI), 
100!M ATP, CTP, GTP, UTP (Amersham Pharmacia Piscataway, NJ), 0.8mg/ml 
acetylated BSA (Promega Madison, WI), 8mM DTT (Promega Madison, WI) 20U 
RNasin RNase inhibitor (Promega Madison, WI), and 1.6 !M 7-methyl GTP cap analog 
(New England BioLabs Beverly, MA) in a 50 !l volume and incubated for 2 hours at 
37°C.  After 2 hours 10 units of RQ1 DNase was added to each reaction and incubated 
an additional 15 minutes at 37°C to digest template DNA.  Each transcription reaction 
was phenol:chloroform : isoamyl alcohol (25:24:1)  extracted twice, chloroform 
extracted twice and loaded onto a microcon10 microconcentrator (Millipore Bedford, 
MA) and centrifuged at 14,000xg for 30 minutes.  The cartridge was removed and 100 
!l of depc (Sigma St. Louis MO) treated H20 was added, the cartridge was inverted and 
centrifuged again at 1,000xg for 3 minutes.  The purified RNA was ethanol precipitated 
and quantitated by spectrophotometry at O.D.260. 
Targeted recombination.  Targeted recombination was conducted by infecting 2.5x105 
L2’s at an M.O.I. of 1 with Alb4 for 2 hours for each B36 mutant and wild type B36 
control.  At the end of 2 hours L2’s were washed the twice with Ca2+ and Mg2+ free PBS 
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(Invitrogen Carlsbad, CA) followed by addition of 400ul of Ca2+ and Mg2+ free PBS and 
1!g of DI RNA for each DI.  Electroporation reaction consisting of DI RNA, Alb4 
infected L2’s, and PBS was electroporated using two consecutive pulses of 0.8 KV, 
maximum resistance, and 25 !F in a 0.2cm gap cuvette (Bio-Rad Hercules, CA) using 
the Gene Pulser II (Bio-Rad Hercules, CA).  Each electroporation reaction received 
500!l of DME10 immediately after electroporation and the whole of each suspension 
was overlayed onto individual T-75 flasks of 75% confluent 17Cl-1 cells and incubated 
at 34°C until syncitia enveloped roughly 80-85% of the monolayer.  The cells were then 
frozen at -80°C thawed, refrozen twice, and sonicated on ice for 3 pulses of 30 seconds 
at 30% power, peak envelope power 100 watts, in a cup probe using a Heat Systems 
Sonicators Ultrasonic Processor XL (Heat Systems Sonicators Farmingdale, NY).  The 
resulting suspension was then centrifuged for 15 minutes at 2,500xg at 4°C.  The 
supernatant was removed and stored at -80°C for subsequent selection of recombinant 
viruses. 
Heat treatment of potential recombinant viruses.  To determine the optimal 
conditions for eliminating as much parental Alb4 as possible, 1.0x106 pfu of A59 and 
Alb4 were heated to 40ºC for 12, 24, 48, and 72 hours.   Heat treated virus was assayed 
by serial 10-fold dilution on L2 cells overlayed with 0.8% agarose and DMEM 2% 
serum, incubated for 2 days at 34ºC, and stained with crystal violet.  Twenty-four hours 
gave the best results, 70% of Alb4 was eliminated and 40% of A59 was eliminated.  In 
time points past 24 hours the amount of A59 that was heat inactivated substantially 
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increased and equaled the amount of Alb4 eliminated.  Twenty-four hours at 40ºC was 
adapted as the standard conditions for all of the targeted recombination experiments. 
Plaque purification of recombinants.  One-milliliter aliquots of harvested virus were 
heat inactivated for 24 hours at 40°C to reduce non-recombinant Alb4 levels in the virus 
suspension.  The heat-treated aliquot was then plated at serial 10 fold dilutions on L2 
monolayers and overlaid with 0.8% agarose and DMEM 10% serum.  Two replicates 
were made, one incubated at 39°C and the other incubated at 34°C for 48 hours as a 
control.  Plaques isolated from the 39°C portion were then extracted with a pasteur 
pipette and placed in 1ml of DME 2% serum.  500!l of each isolate was inoculated to a 
60mm Nunc tissue culture dish (Nalgene Roskilde DE) 65% confluent with 17Cl-1cells 
and incubated at 34°C.  Isolated virus was then grown until syncytia involved 90-95% of 
the monolayer.  The media was then drawn off the monolayer and stored at -70°C, the 
monolayer was washed once with dPBS and total cellular RNA was isolated using the 
RNeasy mini kit (Qiagen Valencia, CA). 
RT-PCR and sequencing of isolated virus.  RT-PCR was carried out using the primer 
17TG with the sequence 5' TTTTTTTTTTTTTTTTTG, which should select any mRNA 
with a C residue 5' to the poly (A) tail, including viral RNA.  RT reactions were carried 
out by following Invitrogen’s protocol for SuperScript II RNase H- Reverse 
Transcriptase (Invitrogen Carlsbad, CA).  Five hundred nanograms of 17TG was 
incubated with 1 !g of total RNA with 1.2mM dNTP’s in a volume of 12 !l, incubated 
at 65°C for 5 minutes and chilled on ice for 2 minutes.  Following the first incubation 
step, Invitrogen’s 5X 1st strand buffer was added to 1X concentration with 10 !M DTT 
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and depc water in a volume of 19!l, this mix was incubated at 42°C for 2 minutes then 
200 units (1!l) of SuperScript II was added and incubated at 42°C for 50 minutes 
(Invitrogen Carlsbad, CA).  The RT was heat inactivated at 70°C for 15 minutes.  PCR 
was carried out on one microliter of RT product using the primers B36For 
(5'TAGTACTCTACCTGGTTTT) and B36Rev (5'ATTGCAGGAATAGTACCC).  PCR 
conditions were 34 cycles of 95ºC for 30 seconds, 40ºC for 60 seconds and 72ºC for 60 
seconds, followed by a final extension for 15 minutes at 72ºC.  B36For and B36Rev, 
flank the 87 nucleotide deletion, B36For is identical to the upstream primer used by 
Masters et al. (63). B36Rev is located downstream of the primer Masters et al. used.  
Our primer generates a slightly larger product, these primers were used because we 
wanted to avoid the artifactual product of smaller size noted by Koetzner and Masters 
(63).  We were unsuccessful and the artifactual band persisted in our experiments as 
well.  When a recombination event occurred a 542bp fragment was produced and when a 
non-recombinant had been isolated a 455bp fragment was produced.  PCR products were 
resolved on 2% agarose gels run with a Phi-X 174 Hae-III marker (Invitrogen Carlsbad, 
CA) to determine if the isolated virus was a recombinant or a parental Alb4.  Positive 
PCR reactions (larger 542bp band) were used as templates for sequencing reactions.  
PCR for sequencing reactions was carried out using the B36For and 17TG primers under 
the conditions used for screening.  A total of 4 PCR reactions were combined and gel 
purified using the Wizard PCR purification kit (Promega Madison, WI) quantitated and 
sequenced using the primer 5666 (5'GTAGTGCCAGATGGGTTA), and the Big Dye  
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Figure 17. Overview of the selection process for Alb4 recombinants.  
The red arrows indicate the primers used for screening selected plaques. 
Pick colonies and screen by RT-PCR and sequencing
Alb4
B36 and mutant DIís
Recombinant virus
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Terminator kit (ABI Foster City, CA).  The program Sequencher (Gene Codes 
Corporation Ann Arbor MI) was used to evaluate the sequences. 
Results 
Construction of DI B36 mutants.  Construction of the DI-B36 mutants began with site-
directed mutagenesis of a subcloned fragment of pB36.  Introducing the mutations into a 
subcloned piece of B36 followed by restriction fragment exchange was chosen as a 
mutagenesis strategy rather than directly introducing mutations into pB36.  This avoided 
the need to sequence the entire B36 insert. Sublconing allowed us to make 1 template to 
carry out our mutagenesis, sequence 3-4 potential mutants and subclone the fragment 
back into parental pB36 and sequence the 3' terminal 350 nucleotides to ensure our 
mutation was present. 
Targeted recombination.  Targeted recombination was carried out as described in 
Materials and Methods and the procedure is overviewed in Figure 17.  After isolation, 
individual plaques were named based upon the experiment number, the mutation they 
were expected to carry, and the size of the plaque (small, medium, or large).  See Figure 
18.  Plaque sizes varied from 5 mm down to what looked like pinheads less than 1.0mm.  
Alb4 is reported to produce 1.0-1.5 mm plaques at 39ºC and A59 wild type size plaques 
of 3.0 to 3.5 mm at 37ºC (42).  Small plaques were judged at anything smaller than 1.5 
mm, medium plaques ranged from 1.5-3.0 mm, and large plaques were 3.0 mm and 
greater.  Cultures of individual viruses were grown and RNA was extracted from the 
infected cells.  Isolated RNA was reverse transcribed and PCR was performed on the 
cDNA; if found to be a recombinant, a large 542 bp band versus a smaller 455 bp Alb4  
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Figure 18. Plaque dilution of ATW5', B36, and A59 controls.  
The large white arrows indicate what were considered large 
plaques, the hashed arrow indicates a medium plaque, and the 
dashed arrow indicates a small plaque.  The large plaques were 
picked from the ATW5' wel l, screened by RT-PCR and 
sequenced.  The small plaque in the B36 well is most likely an 
Alb4 non-recombinant, and the A59 is an example of wild type 
(large) plaque size.
ATW5'                          A59          B36
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Figure 19.  RT-PCR of potential mutant recombinants.  The white 
vertical arrow indicates an Alb4 virus used as a control, the horizontal 
arrow indicates the larger band of interest which represents a 
recombinant virus.  Lane M is the Phi-X HaeIII marker, Lane + is the 
pB36 PCR control, Lane A is the no RT control, Lane B I s the no RNA 
control, Lane E  through K  represent ATW5'  potential mutant  
recombinant viruses.
M     +     A    B     C     D      E     F     G      H    I      J       K
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band, it was sequenced.  See Figure 19.  The smaller band in PCR screening assays was 
common to all experiments and is noted by Koetzner et al. as well (63).  In most cases 
 medium and large plaques were recombinant viruses, and small plaques were Alb4 that 
survived the selection process.  Only 4 out of 20 small plaques screened were 
recombinant, viruses.  All recombinant plaques were sequenced and found to be wild 
type; this indicated an even number of recombination events had occurred and that under 
these conditions the mutations that we introduced could not be recovered.  The results 
are summarized in Table 5.  
Conclusions 
Targeted recombination failed to introduce the mutations ATW, ATW5', ATW3', 
MT2A, MT3C, M24C into the deletion mutant Alb4 to produce a mutant recombinant 
virus.  The restoration of wild type sequence in all selected viruses indicates an even 
number of crossovers occurred during recombination to restore the wild type primary 
structure.  The data do not exclude the possibility that the mutations introduced were 
lethal to the virus, the data only indicate that using this technique that the even number 
crossover recombinant viruses that were isolated and sequenced were favored and any 
mutant virus that did replicate, replicated below our level of detection. 
One possible explanation for not recovering mutant virus is that the heat 
treatment of the virus and the temperature used for plaque isolation (39°C) favored 
survival of recombinants containing an even number of crossovers and thus the wild type 
sequence.  The isolated viruses were grown at 34°C to reduce the possibility of 
overlooking a mutant recombinant virus that was temperature sensitive.  Unfortunately  
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this mainly selected Alb4 virus that had not been killed in the heat treatment, 59 out of 
87 total plaques as screened by RT PCR.  Based upon plaque size 67 large and medium  
plaque phenotype potential recombinant viruses were screened by RT-PCR, of the 67 
plaques screened 24 were recombinants.  In order to avoid missing a small plaque 
phenotype recombinant mutant virus 20 small plaques were also screened by RT-PCR 
and 4 of them were identified as recombinants.  Unfortunately in all cases the 
recombinants isolated restored wild type sequence. It is also possible that the mutant 
recombinants were so impaired in one or many steps of replication, that the rarer even 
number recombinants were able to out compete the mutant recombinants in the initial 
stages of infection, thus selecting against the mutant recombinants and allowing only 
survival of the even numbered wild type recombinants.  In order to investigate this 
possibility it was decided to use B36 as a DI in replication experiments of 32PO4 labeled 
DI transfected helper virus (A59) infected cells.  Those experiments are discussed in 
Chapter IV.  To address the lethality of mutations an infectious cDNA clone of MHV-
A59, which has only recently become available from Ralph Baric, was used to 
incorporate our mutations and is discussed in detail in Chapter V. 
Master’s lab has developed another targeted recombination system that uses a 
construct, pFMHV, that carries genes 3-7 of MHV-A59 but the MHV spike protein has 
been replaced with the spike protein from Feline Infectious Peritonitis Virus (45).  The 
recombinant virus is grown on BHK cells expressing the feline Aminopeptidase N 
protein, which were developed by Kathryn Holmes’ lab (100).  Aminopeptidase N 
serves as the ligand for feline spike protein and BHK cells expressing Aminopeptidase N 
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grew FIPV to equal titer as the normal host cells. The restriction of the spike protein 
allows for better selection of recombinants than the DI B36 based system, because 
practically all of the background is removed.  We chose to use the DI B36 based system 
even though selection would be more difficult because the pFMHV at roughly 8.7 kb is 
nearly 4 times the length of DI B36 increasing the likelihood of recombinants derived 
from an even number cross-over event with wild type sequences.  Given the results 
generated it is doubtful that the feline system would have yielded advantageous results. 
Even with the FIPV system Masters’ lab has had only moderate success in 
generating virus with mutations in the 3' UTR.  To investigate the role of the 68 nt stem-
loop structure Masters attempted to introduce clustered point mutations using the B36 
system, for the fifteen mutants they screened they were able to generate nine with the 
B36 system, the remaining six they tried to obtain using the feline system.  None of the 
six mutations could be generated using the B36 or FIPV targeted recombination systems.  
When the six mutations were explored with DI B36 in replication assays all six 
recombined to restore wild type sequence (33). 
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CHAPTER IV 
 
DI B36 REPLICATION ASSAYS OF THE 3'42 NUCLEOTIDE HOST PROTEIN 
BINDING ELEMENT 
 
 
Introduction 
 To determine the role of the 3'42 nucleotide host protein binding element in 
MHV replication mutant probes were developed and tested for their effect on host 
protein binding.  Six of the probes assayed did not bind as well as wild type and two of 
the probes bound better than wild type.  To test the effects of the mutants in vivo, 
targeted recombination was used to attempt to create a mutant virus as discussed in 
Chapter III.  Unfortunately the viruses recovered in targeted recombination experiments 
underwent an even number of recombination events that restored wild type sequence, 
regardless of the mutant DI RNA used as the donor.  The goal of the project was to 
determine the role of the 3' 42 nucleotide host protein binding element in the virus life-
cycle, since a mutant virus could not be constructed, DI RNA replication assays were 
adapted to at least determine what role, if any, the 3' 42 nucleotide host protein binding 
element has in replication.  DI B36 has been shown by Masters (42, 63) to function as a 
DI RNA in the same manner as DIssE (40, 41, 61) when transfected into virus infected 
cells. 
 B36 and the B36 mutants developed in Chapter II were used in DI RNA 
replication experiments, mutants MT2A, MT3C, and M24C recombined to restore wild 
type sequence in all experiments attempted.  Mutants ATW, ATW5', and ATW3' did not 
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replicate and when sequenced were found to maintain their mutations.  Mutants ATW, 
ATW5', and ATW3' all produced negative strand RNA’s, in relatively equal amounts 
when compared to wild type B36 using semi-quantitative PCR.  However the mutants 
failed to produce positive strand RNA’s that could be detected by the DI RNA 
replication assay.  The data suggest a role for the 3' 42 nucleotide host protein binding 
element in production of positive strand RNA’s. 
Materials and Methods 
Cells and virus.  17Cl-1 cells, a spontaneously transformed NIH 3T3 fibroblast cell line, 
were maintained at 37°C and 5% CO2 in DMEM (Invitrogen Carlsbad, CA) 
supplemented with 10% calf serum (HyClone, Logan UT).  L2 cells were maintained at 
37°C and 3% CO2 in DMEM supplemented with 10% calf serum (HyClone, Logan UT).  
A59 was used as helper virus for all experiments. 
Transcription of DI RNA’s.  DIssE was used as a transfection control (61).  The B36 
DI RNA’s used in this experiment are the same DI RNA’s used in Chapter III and their 
construction is described therein.  Transcription reactions were carried out using the 
mMessage mMachine kit from Ambion Austin, TX (Ambion Austin, TX) following the 
manufacturer’s instructions except for purification of DI RNA’s.  Purification of DI 
RNA’s was carried out as in Chapter III. 
B36 DI replication assays.  The method established by Masters’ lab was used with 
extensive modifications (63).  17Cl-1 and L2 cells were grown on monolayer to 
confluency. 17Cl-1 cells were washed, trypsinized, centrifuged, and resuspended in 
DME10 and seeded onto six well cluster plates (Corning Corning NY) at a density of 
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1.0x106 cells/ well in 3 ml of DME10 prior to preparation of the L2 cells.  The 17Cl-1’s 
were washed twice with DME2 2 hours after being plated onto the 6 well cluster plate 
and fed with 2 ml of DME2 just prior to electroporation of the L2 cells.  L2 cells were 
prepared for electroporation by the following method: L2 cells were trypsinized, washed 
in DME10% serum, counted, centrifuged at 1,000xg, the media was aspirated and cells 
were resuspended in DME2 to a concentration of 1.0x106 L2 cells/ml.  For each DI RNA 
1.0x106 L2 cells were infected at an M.O.I. of 3 for 2 hours.  After 2 hours of infection 
L2 cells were centrifuged at 1,000xg and resuspended in 10 ml Ca2+, Mg2+ free PBS 
(Invitrogen Carlsbad, CA) and centrifuged again at 1,000xg this wash procedure was 
repeated 2 times.  For each DI RNA plus a mock transfected control 1.0 x106 L2 cells 
per DI RNA were electroporated with 5 µg of DI RNA or without RNA for the mock 
transfected control at maximum resistance, 0.8KV and 25!F for 2 pulses 5 seconds 
apart.  The electroporated cells were then resuspended in 1 ml of DME2 and overlayed 
onto the 17Cl-1 cells. 
The overlayed-infected-electroporated cells were incubated until syncytia 
consumed roughly 65% of the monolayer usually 8-10 hours post infection.  At this 
point the DME2 was removed and replaced with 2 ml phosphate free DMEM (Invitrogen 
Carlsbad, CA) with 2.5 µg /ml Actinomycin D (Calbiochem -Novabiochem San Diego, 
CA) and incubated at 37ºC for 20 minutes.  At the end of 20 minutes the media was 
replaced with phosphate free media containing 2.5 µg /ml Actinomycin D, 2% dialyzed 
serum, and 0.5 mCi of 32PO4 (ICN Irvine, CA) and incubated at 37ºC until syncytia 
enveloped 90-95% of the monolayer, usually 14-16 hours post infection.  RNA was 
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extracted either with the RNeasy kit from Qiagen (Qiagen Valencia, CA) or by 8M 
guanidium HCL extraction and ethanol precipitation.  Three to six µg of RNA was 
denatured in RNA loading buffer [final concentration 0.5X MOPS, 50.5% formamide 
(Sigma St. Louis, MO), 18% formaldehyde (EM Science Gibbstown, NJ), 5% glycerol 
(EM Science Gibbstown, NJ) and 0.02 µg ethidium bromide (Sigma St. Louis, MO)] 
onto a 1% SeaKem GTG (FMC Rockland ME) 18% formaldehyde (EM Science 
Gibbstown, NJ) 1X MOPS buffer gel and electrophoresed in 1X MOPS buffer which 
contained 18% formaldehyde for 6 hours at 120V constant voltage.  Gels were exposed 
to UV light and photographed, fixed in 80% methanol (EM Science Gibbstown, NJs) 
dried and exposed to Biomax MS film (Kodak Rochester, NY).  If DI RNA accumulated 
positive strand, as seen by a band which migrates between mRNA’s 6 and 7, the DI 
RNA was quantitated using Molecular Dynamics Phosphorimager and Storm 8.2 
software, three experiments for each set of mutants were used to generate an average 
(Amersham Pharmacia Piscataway NJ).  The ethidium bromide stained gel was used to 
normalize to wild type B36 (set at 100%) to adjust for miniscule differences in 
quantitation and loading. 
RT-PCR and sequencing.  Total RNA of each culture underwent reverse transcription 
using Invitrogen Carlsbad, CA’s Superscript II RT following the manufacturer protocol 
with one !g of total RNA from each DI RNA evaluated and 2 pmoles of primer B36n-1 
(5'GGCTTCCTATTTACATCC) (Sigma Genosys The Woodlands,TX) which is specific 
to the negative strand B36 DI RNA.  This ensured that only replicated DI B36 would be 
detected.  No RT and no RNA controls were included in the RT step.  The no RT control 
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used extracted RNA from the B36 DI RNA transfected culture to ensure that residual 
digested transcription template DNA was eliminated and not amplified by PCR.  PCR 
reactions for each DI RNA was carried out with 31 cycles of 95°C for 30 seconds, 35°C 
for 60 seconds, 72°C for 90 seconds, followed by a fifteen-minute extension at 72°C 
using 200 nM primers B36n-1 and 17TG (5'TTTTTTTTTTTTTTTTTG) (Sigma 
Genosys The Woodlands, TX) with one unit of Taq DNA polymerase, 1X PCR buffer 
(Invitrogen Carlsbad, CA), 1.5mM MgCl2 (Invitrogen Carlsbad, CA), 200 !M dNTP 
(Amersham Pharmacia Piscataway, NJ) mix, and1!l of RT product as template in a 50!l 
volume.  PCR products were electrophoresed on a 1.0% 1X TAE Seakem LE (FMC 
Rockland ME) at 90 volts, stained with ethidium bromide, and photographed. 
The RT products for each DI RNA were amplified further, using the conditions 
listed above, for sequencing.  Four PCR reactions were combined and gel purified using 
the Wizard PCR preps (Promega Madison, WI).  Purified cDNA was sequenced using 
the 3 pmoles of primer 5666 (5'GTAGTGCCAGATGGGTTA), 8!l of the Big Dye 
terminator kit (ABI Foster City, CA) and 600 ng of template using the following 
protocol in a 20!l reaction: 98°C for 30 seconds, 50°C for 15 seconds, and 60°C for 4 
minutes for 24 cycles.  Sequencing products were purified using a Bio-Spin 30 column 
(Bio-Rad Hercules, CA).  Columns were prepared by warming to room temperature, 
letting resin settle for 1 hour, and centrifuged at 700xg for 2 minutes.  After preparation 
of the column, the reaction was added and centrifuged again at 700xg for 2 minutes (Dr. 
David Needleman, UTMS-H personal communication).  Samples were then dried and 
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analyzed by the Gene Technologies Lab at Texas A&M University using ABI (ABI 
Foster City, CA) 377 and 371 automated sequencing gels. 
Semi-quantitative RT-PCR.  Semi-quantitative RT-PCR was carried out to determine 
if the relative amount of negative strand produced was equal in the DI RNA’s that 
maintained their mutations.  Two micrograms of total RNA was incubated with 100 ng 
of random hexamers (Invitrogen Carlsbad, CA) and 5mM dNTP’s (Amersham 
Pharmacia Piscataway, NJ) for 5 minutes at 65°C, followed by a 10 minute incubation at 
25°C, then a reaction mixture consisting of 1X First-Strand Buffer (Invitrogen Carlsbad, 
CA), 10 mM DTT (Invitrogen Carlsbad, CA) was added in a final volume of 19 !l, and 
incubated for 1 minute at 42°C, finally 1 !l of Superscript II Reverse Transcriptase (200 
units) (Invitrogen Carlsbad, CA) was added and incubated for 50 minutes at 42°C.  
Superscript II was heat inactivated at 70°C for 15 minutes, and reactions were stored at -
20°C until needed.   
 PCR was carried out on 2 !l of each RT reaction using one unit of Taq DNA 
polymerase, 1.5mM MgCl2 (Invitrogen Carlsbad, CA) at 1X PCR buffer concentration 
[diluted from 10X stock (Invitrogen Carlsbad, CA) with 200 nM each primer, and 200 
!M dNTP (Amersham Pharmacia Piscataway, NJ) Primers B36n-1 and B36rev 
(5'ATTGCAGGAATAGTACCC) (Sigma Genosys The Woodlands TX) were used 
along with primers GAPDH-1 (5' GCCAAAAGGGTCATCATCTC) (Sigma Genosys 
The Woodlands, TX) and GAPDH-2 (5' GTAGAGGCAGGGATGATGTTC) (Sigma 
Genosys The Woodlands, TX) under the following conditions: 94°C 60 seconds, 55°C 
for 60 seconds, 72°C for 4 minutes for 30 cycles.  Individual reactions were removed at 
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cycles, 14, 18, 22, 26 and 30, electrophoresed on 1.5% SeaKem LE (FMC Rockland 
ME) for 2 hours at 90 volts constant and stained with ethidium bromide (Sigma St. 
Louis, MO).  RT-PCR products were analyzed by densitometry using the Storm 8.2 
software package (Amersham Pharmacia Piscataway, NJ). 
Results 
DI RNA replication assays.  DI RNA replication experiments were carried out as 
described in Materials and Methods.  For simplicity, replication assays were performed 
in two groups, the first with the mutants involving the 11nt host protein binding motif.  
The second group consisted of the mutants which were based upon the more recent 
Mfold data, two of which, ATW and ATW3', formed RNP complexes at higher levels 
than wild type probe in gel mobility shift RNase T1 protection assays. 
The first set of mutants analyzed were MT2A, MT3C and M24C.  Mutant MT2A 
was chosen because it was the mutant that had the greatest effect on host protein binding 
that also maintained wild type computer predicted secondary structure.  MT3C was 
chosen because it had the greatest effect on RNP formation and the most drastic change 
in secondary structure of any of the mutants that were developed based upon Yu and 
Leibowitz’s data (109).  M24C was chosen because it carries the second site mutant of 
the deleterious MT3C mutant, this mutant increased binding activity to 74.1% of wild 
type probe from 6.3% and restored wild type computer predicted secondary structure, 
establishing a possible connection between secondary structure and RNP complex 
formation.  Three complete experiments were used to determine an average DI RNA 
replication efficiency.  A complete experiment was defined as one in which DI B36  
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RNA and DIssE RNA both replicated to detectable levels regardless of how well the 
mutant DI RNA’s replicated, and time constants for all electroporations was 0.8, 
indicating that electroporation conditions were optimal.  Mutants MT2A, MT3C, and 
M24C all appeared to produce positive strand DI RNA with varying efficiency 
compared to wild type DI B36 as detected by metabolic labeling.  Quantitation by 
phosphorimager analysis revealed that MT2A replicated 5% better than B36, MT3C 
replicated 78% as well as B36, and M24C replicated 69% as efficiently as B36.  See 
Figure 20.  In order to determine if replicated DI RNA’s had maintained the intended 
mutation, RT-PCR for negative strand RNA was carried out for DI RNA’s MT2A, 
MT3C, and M24C.  See Figure 21.  Negative strand was amplified because positive 
strand DI RNA was transfected, so it becomes impossible to differentiate between input 
positive strand DI RNA and replicated positive strand DI RNA.  Upon sequencing it was 
apparent that the mutant DI RNA’s had undergone recombination events which restored 
the wild type sequence and the ability of the DI RNA to replicatein all three 
experiments.  Recombination was not entirely unexpected since recombination to restore 
wild type sequence is a common occurrence in DI RNA replication experiments (33, 56, 
109, 110). 
 The same conditions were used to test the replication efficiency of the second set 
of mutants ATW, ATW5', and ATW3'. In contrast to the first set of mutants ATW, 
ATW5', and ATW3' did not replicate nearly as efficiently as DI B36 and were generally 
undetectable by metabolic labeling.  Sequencing was carried out by RT-PCR for 
negative strand DI RNA followed by sequencing of the PCR products to determine if the  
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M         A       B     C         D E F        G        H     I
Figure 21.  A representative RT-PCR for negative strand DI RNA.  Lane 
M=100 bp marker, Lane A=No RT control, Lane B=No RNA control  Lane 
C=pB36 PCR control, Lane D=A59  mock transfected, Lane E=DIssE, 
Lane F=B36 DI, Lane G=MT2A, Lane H=MT3C, Lane I=M24C.  These 
products were amplified and used as sequencing templates.
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intended mutations had been maintained.  The results indicated that for the three 
complete experiments obtained, in two of the three experiments the mutations were 
maintained in ATW, ATW5', and ATW3'.  In one of those two experiments ATW3' 
replicated at 4% of B36 levels and was undetectable in the other, while ATW and 
ATW5' were undetectable by phosphoimager analysis in both experiments.  See Figure 
22. 
In the third experiment sequencing data indicated a mixed population of DI’s.  
Some of the mutant nucleotides were reverted to wild type within the DI population, 
while part of the population had either a mutant or wild type base in a particular position.  
Sequencing was repeated for these DI’s with the identical results.  The double mutant 
ATW was supposed to carry the sequence 2U, 3G, 4A, 5U, 23A, 24U, 25C, 26A.  
Positions 2, 24, and 25 maintained their mutations.  Position 3 was ambiguous for wild 
type C and mutant G, position 4 reverted to wild type, and position 5 was ambiguous for 
wild type A or mutant U.  Positions 23 and 26 were ambiguous for mutant A or wild 
type U.  With this nucleotide configuration the DI ATW population replicated 65% as 
well as wild type DI B36.  Mutant DI ATW5' underwent a similar event which restored 
part of the wild type sequence and it replicated 71% as well as wild type DI.  DI ATW5' 
has the mutations 23A, 24U, 25C, 26A from wild type 23U, 24A, 25G, and 26U, 
sequencing revealed that positions 24 and 25 maintained their mutations while positions 
23 and 26 were ambiguous for mutant A or wild type U.  DI ATW3' also restored part of 
its sequence to wild type.  DI ATW3' has mutant nucleotides of 2U, 3G, 4A, 5U, 
sequencing revealed it restored wild type at positions 3 and 4 (A and C respectively),  
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maintained its mutant at position 2, was ambiguous at position 5 for wild type A or 
mutant U, and position 24 which was not targeted for mutation in this DI was ambiguous 
for A or U with A being the wild type nucleotide.  In this experiment the ATW3' DI 
population replicated 13% better than wild type DI B36. 
Semi-quantitative RT-PCR.  Semi-quantitative RT-PCR was carried out for the 2 
ATW, ATW5', and ATW3' DI RNA replication experiments in which positive strand 
was not detected and sequencing indicated that mutations were maintained.  The results 
indicate that negative strand ATW5' mutants produced more negative strand RNA than 
B36 and ATW3' and ATW are produced below levels of B36.  See Figure 23.  Upon 
densitometric analysis of the data using the Storm software package indicates the 
differences in negative strand production is not as drastic as it appears on the ethidium 
stained gel and the negative strand produced by each mutant DI RNA is near to wild 
type DI B36 levels.  Overzealous background correction by the software may account 
for this disparity. 
Conclusions 
 Data for the first set of mutants MT2A, MT3C, and M24C are not unusual as 
recombination to wild type sequence occurs frequently in DI experiments (33, 56, 57, 
109, 110).  Recombinants indicate that the introduced mutations were selected against, 
and deleterious when compared to the wild type sequence.  The intended mutant DI 
RNA could still be viable, but replicated at a much lower level than wild type.  When the 
recombination event(s) that restores wild type sequence occurred, the wild type sequence 
is obviously replication competent and becomes the predominant species as seen in our  
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Figure 23.  Semi-quantitative RT-PCR of negative strand B36, ATW, ATW3', and 
ATW5' DI's g enerated in DI replication assays. The upper bands are the DI  negative 
strand specific bands, and the lower band indicate the GAPDH controls.  Samples of 
each DI were removed at 14, 18, 22, 26, and 30 cycles of PCR and electrophoresed as 
described in Materials and Methods. 
Marker             B36                          ATW             ATW3'        ATW5'
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sequencing data.  The differences in amount of wild type recombinant DI RNA produced 
is also not unusual, in Liu’s recent work several recombinants with restored wild type 
sequence replicated at lower efficiencies than wild type DIssE (57).  It is unknown if the 
lower replication efficiency observed for MT3C and M24C is relevant.  It is possible that  
several recombination events took place and the lag between the time recombination 
started and the correct sequence was arrived at did not allow enough time for 
recombinant DI B36 to accumulate to wild type levels.  It is also possible that there is an 
effect on host protein binding that is initial, deleterious, and short-lived and then 
recombination occurs after the initial effect is overcome, either by recognition of the 
polymerase complex by a signal within the 3' UTR, or use of a redundant system that 
allows replication to proceed after recombination has occurred.  
 Mutants ATW, ATW5', and ATW3' indicate that mutations in the 3' terminal 42 
nucleotide host protein binding element disrupt positive strand synthesis.  No positive 
strand synthesis could be detected by radiolabeling with 32PO4 and exposure to a 
phosphoimager.  Semi-quantitative RT-PCR indicates that negative strand synthesis is 
not significantly affected by introduced mutations.  Data from Lin et al. suggest that the 
3' terminal 55 nts plus poly (A) tail are essential for negative strand synthesis in DI 
constructs (55).  The mutations we introduced into the region indicate did not 
significantly effect negative strand synthesis but had greatly decreased levels of positive 
strand synthesis.  It is possible that our mutations were not in the proper location of the 
region to effect negative strand synthesis and that other mutations in the 3' terminal 55 
nts might produce a phenotype that is negative strand defective. 
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 The experiment in which partial restoration of wild type sequence was observed 
provides some evidence of which nucleotides are important for positive strand synthesis.  
The nucleotides that remained mutants probably have little effect on positive strand 
synthesis, those nucleotides are 2, 24, and 25.  Nucleotide 4 was the only position that 
returned to wild type in the mutant DI RNA’s carrying a 4A (ATW and ATW3'), 
suggesting that a wild type C at this position is necessary for positive strand synthesis.  It 
is impossible to distinguish the contribution of individual nucleotides that were 
ambiguous  (nucleotides 3, 5, 23, and 26) in positive strand synthesis from the data 
generated.  The data from the partial sequence restoration experiment indicates that the 
sequence carried would restore DI positive strand replication, the ATW3' mutant 
actually replicated better than wild type B36 DI, and ATW and ATW5' replicated at 
lower efficiencies 65 and 71%, but this is one experiment so the data are not conclusive.  
In order to test the specific effects of each position a set of mutants will have to be 
developed that carry single point mutations or other combinations of the mutated 
nucleotides in question, instead of the arrangement of clustered point mutations used in 
this experiment.  
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CHAPTER V 
 
DETERMINING THE ROLE OF THE 3' 42 NUCLEOTIDE HOST PROTEIN 
BINDING ELEMENT OF THE MHV 3' UTR USING THE cDNA INFECTIOUS 
CLONE 
 
 
Introduction 
 
 DI replication experiments demonstrated that mutations in the 3' terminal 42 
nucleotide host protein binding element had effects on replication of DI RNA’s.  Three 
of the mutants studied had deleterious effects on positive strand synthesis, while three 
other mutants recombined to restore functional wild type sequence.  Recombination to 
wild type sequence essentially masked any mutant DI RNA that may have replicated 
poorly in the background of a normally replicating wild type DI population.  
Recombination also impaired our ability to construct mutant viruses using targeted 
recombination.  In order to eliminate recombination, infectious cDNA clones carrying 
mutations explored in Chapters III and IVs were constructed using Ralph Baric’s MHV-
A59 infectious clone system (108). 
 Yount et al. recently described the construction of infectious cDNA clones for 
TGEV and MHV (107, 108).  Their approach was to generate stable cDNA fragments of 
the genome, ligate them together in gene order so that reading frame of the MHV 
genome was intact.  RNA is then transcribed from the assembled fragments, transfected 
into BHK cells, and isolate viruses from plaques generated.  BHK cells were used 
because they are easier to manipulate and have been previously shown to produce MHV  
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Figure 24. Panel A shows an example of construction of the template for 
infectious clone generation using the enzyme Esp3I.  Esp3I recognizes a 
specific sequence 5'C GTCTC(N), cuts 3' to position (N) leaving a 4  
nucleotide overhang that is non-palindromic when ligated with another 
similarly engineered Esp3I cut fragment.  Panel B shows the arrangement of 
fragments and their restriction sites that allow for full length template 
assembly. 
ATGGCTGAGACGNNNNN-3'
TACCGACTCTGCNNNNN-5'
Esp3I
5'
3'
MHV A FRAGMENT 5'-NNNNNCGTCTCATGGC
3'-NNNNNGCAGAGTACCG
Esp3I
MHV B FRAGMENT
3'
5'
MHV B FRAGMENT
3'
5'
5'
3'
MHV A FRAGMENT
ATGGC
TACCG
A.
MHV-A59 POLYMERASE MHV STRUCTURAL GENES
MHV A
MHV B
MHV C
MHV D
MHV E
MHV F
MHV G
Esp3I
Bgl1
Esp3I Esp3I
Esp3I
Esp3I Sfi I
T7
B.
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at equal levels to 17CL-1 and DBT cells when BHK cells express the MHV receptor 
(100). 
A similar approach was used to generate the A59 infectious clone.  Taking 
advantage of restriction enzymes that have specific recognition site but cut at a given 
position rather than nucleotide sequence within the restriction site, Baric’s lab was able 
to generate 7 fragments that contain either a Bgl I or Esp 3I site for fragment assembly.  
We obtained fragment G which contains the 3' terminal 8.7 kb of the MHV A59 genome 
encompassing genes 2 through 7, the 3' UTR, and approximately 100 nucleotide poly 
(A) tail.  The 5' end of fragment G contains an Esp3I site and the 3' end contains a Sfi I 
site, these sites are used to liberate the G fragment.  G is then ligated to F fragment in a 
specific orientation due to the Esp3I site at the 3' end of F fragment.  See Figure 24 for 
details.  Fragment G was modified from pMH54 to introduce the Esp 3I site (108).  
Plasmid pMH54 was developed by Paul Masters for the FIPV spike protein based 
targeted recombination system (45).  Our intent was to introduce our mutations into the 
G fragment by restriction fragment exchange between the unique Nru I site of the G 
fragment and pB36 and a Pac I site introduced into the Nsi I site just 3' to the poly (A) 
tail of pB36.  Ideally, the mutants would be viable, but have unique phenotype when 
compared to wild type A59, but given the data from Chapter IV it is possible that 
mutants ATW, ATW5', and ATW3' would not produce a virus, and only accumulate 
negative strand viral RNA’s, while mutants MT2A, MT3C, and M24C would not be 
viable. 
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Materials and Methods 
Cells and virus.  17Cl-1 cells, a spontaneously transformed NIH 3T3 fibroblast cell line, 
were maintained at 37°C and 5% CO2 in DMEM (Invitrogen Carlsbad, CA) 
supplemented with 10% calf serum (HyClone, Logan UT).  DBT cells were maintained 
at 37°C and 5% CO2 in DMEM supplemented with 10% calf serum (HyClone, Logan 
UT).  Wild type MHV-A59 was used as a control for growth curves. 
Plasmids.  Ralph Baric kindly provided the plasmids carrying the appropriate fragments 
of the A59 infectious clone construct.  The plasmid was introduced into TOP10F E. coli 
strain from Invitrogen Carlsbad, CA and grown in LBAMP 50!g/ml for B, C, D, E, and G 
fragments or LBKAN 50 !g/ml for A and F fragments and plasmid was purified using the 
Plasmid Mini Prep Kit (Bio-Rad Hercules, CA).  Multiple colonies of each clone were 
selected and grown individually at 26ºC for 24 hours, fed with the proper media and 
grown an additional 24 hours and screened for the appropriate restriction pattern.  
Positive colonies were then pooled; this provided enough plasmid to carry out all 
manipulations. 
Restriction fragment exchange.  To generate a plasmid that contained compatible 
restriction sites five micrograms of DI B36 mutants generated in Chapter  III, MT2A, 
MT3C, M24C, 24C, ATW, ATW5', and ATW3' were digested with 50 units of Nsi I 
(New England BioLabs Beverly, MA) and digested plasmid was purified from a 1.0% 
NuSeive GTG (FMC Rockland ME) 1X TAE agarose gel using the Qiaquick Gel 
Extraction Kit (Qiagen Valencia, CA) and quantitated by spectrophotometry. One-
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hundred nanomoles of each oligonucleotide B36PacI3' 
(5'GCGCGCTTAATTAACGCGCCGGTGCA) (Sigma Genosys The Woodlands, TX) 
and B36PacI5' (5'CCGGCGCGTTAATTAAGCGCGCTGCA) (Sigma Genosys The 
Woodlands, TX) were annealed together by heating to 95°C for 30 seconds, cooling to 
65°C for 30 seconds, then 2 minutes at 40°C, and then on ice until ligation to introduce a 
Pac I site into the Nsi I site, disrupting the Nsi I site.  Ligations were assembled using 50 
ng of each mutant plasmid and two !l of annealed oligo with 1X T4 ligation buffer 
(Invitrogen Carlsbad, CA), one unit T4 DNA ligase (Invitrogen Carlsbad, CA) in a 20 !l 
volume, incubated for 1 hour at 24°C.  One microliter of each ligation reaction was 
electroporated into JM109’s using the Gene Pulser II (Bio-Rad Hercules, CA) and 0.2 
cm cuvettes (Bio-Rad Hercules, CA) recovered at 37°C and grown in LBAMP at 37°C 
overnight.  Putative Pac I positive plasmids were digested by Pac I (New England 
BioLabs Beverly, MA) and electrophoresed on 1.5% Seaplaque (FMC Rockland ME), 
1X TAE agarose gels and stained with ethidium bromide.  JM109’s with the Pac I-B36 
plasmids were grown and a glycerated stock was maintained at -70°C.  Plasmids were 
purified using the Plasmid Midi Prep Kit (Bio-Rad Hercules, CA), and 10 !g of plasmid 
was digested with Nru I and Pac I, the resulting 178 bp fragment was gel purified from 
1.0% NuSeive GTG (FMC Rockland ME) 1X TAE gels and extracted using the 
Qiaquick Gel Extraction Kit (Qiagen Valencia, CA).  Nru I- Pac I fragments were 
quantitated by electrophoresis on 2.0% Seaplaque (FMC Rockland ME) 1X TAE 
ethidium bromide stained gels run with Low Mass DNA Marker (Invitrogen Carlsbad, 
CA) and quantitated by densitometry using the Alpha Imager 3.24 software (Alpha 
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Innotech San Leandro, CA).  To receive the mutant sequence 10 !g of fragment G was 
digested with 50 units of Nru I and 50 units Pac I and gel purified from a 1.0% Metaphor 
(FMC Rockland ME) 1X TAE agarose gel using the Qiaquick Gel Extraction Kit 
(Qiagen Valencia, CA) and quantitated.  Mutant Nru I-Pac I fragments were ligated into 
Sac I and Pac I digested G fragment using 50 ng G fragment and 2.4 ng of each mutant 
fragment in 1X T4 DNA ligase with 1 unit T4 DNA ligase (Invitrogen Carlsbad, CA) at 
24°C for 1 hour and then transformed into TOP10F’s.  G fragment was grown at 29°C 
for 24 hours followed by colony screening by Esp 3I digestion.  Plasmids which digested 
to produce a 9 kb fragment and 3 kb fragment were sequenced using primer 5666 
(5'GTAGTGCCAGATGGGTTA) (Sigma Genosys The Woodlands, TX) using the same 
conditions as described in Chapter III.  Primer 5666 is upstream of the Nru I site 
confirming the orientation and introduction of mutant sequence into the G fragment.  
Production of the MHV-A59 infectious cDNA clone.  Plasmids containing the A 
fragment of the MHV cDNA were digested with Mlu I (New England BioLabs Beverly, 
MA) and treated with 15 units of calf intestinal phosphatase (New England BioLabs 
Beverly, MA).  BsmB I, an isoschizomer of Esp 3I, was used to liberate the A fragment.  
The B fragment was excised with Bgl I (New England BioLabs Beverly, MA).  C, D, E 
and F fragments were digested from their parental plasmids using BsmB I.  G fragment 
was digested with Sfi I (New England BioLabs Beverly, MA) treated with 15 units of 
calf intestinal phosphatase and digested with BsmB I.  Fragments A, B, C, D, and G 
were electrophoresed on 0.8% Metaphor agarose 1X TAE gels, fragments E and F were 
electrophoresed on 1% Metaphor agarose 1X TAE gels.  All gels were stained with 
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ethidium bromide visualized with Dark Reader technology (Claire Chemical Research 
Denver CO) and the appropriate fragment was excised and purified using the Qiaex II 
gel purification system.  Recovered DNA was quantitated by spectrophotometry.  1.5 "g 
of total DNA composed of each of the fragments in equal molar ratios was ligated using 
50 units T4 DNA ligase at 14°C overnight.  The resulting full-length cDNA template 
was used in in-vitro transcription reactions with the mMessage mMachine T7 kit 
(Ambion Austin, TX) with a 1:1 GTP to cap ratio.  To provide N transcript in trans N 
was amplified from the G fragment using the following primer (5' 
TCGGCCTCGATGGCCATTTAGGTGACACTATAGATGTCTTTTGTTCCTGGGCA
AG) and primer a59Ng3’(-) (5' TCCGGA(TTT)8 
TTACACATTAGAGTCATCTTCTAACC).  The PCR product was gel purified and 
used in in vitro transcription reactions with the mMessage mMachine SP6 kit (Ambion 
Austin, TX).  The transcripts from the T7 and SP6 reactions were electroporated by 3 
pulses at 0.85 kV, and 25"F into 8x106 BHK-R cells.  The electroporation reaction was 
allowed to recover for ten minutes at room temperature and then plated onto DBT cells 
that were 70% confluent in a T-75 flask. 
Plaque isolation.  After electroporation of the assembled infectious clone into MHV 
receptor expressing BHK cells, cultures were incubated for two days. The cells were 
then frozen at -80°C, thawed, refrozen twice, and sonicated on ice for 3 pulses of 30 
seconds at 30% power in a cup probe using a Heat Systems Sonicators Ultrasonic 
Processor XL (Heat Systems Sonicators Farmingdale, NY).  The resulting suspension 
was then centrifuged for 15 minutes at 2,500xg at 4°C.  The supernatant was removed 
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and stored at -80°C for subsequent selection viruses.  To isolate individual viruses an 
aliquot of each mutant was serially 10 fold diluted and incubated on DBT cells 
overlayed with 0.8% agarose and incubated at 37°C for 3 days.  At the end of 3 days 
individual plaques were isolated using a plugged pasteur pipette and innoculated onto a 
70% confluent monolayer of 17Cl-1 cells in a 65 mm tissue culture dish (Becton 
Dickinson and Company Franklin Lakes, NJ) until CPE enveloped 85% of the 
monolayer.  At this point the media was removed and stored at –70°C. 
RNA isolation and sequencing.  RNA from the monolayer of 17Cl-1 cells infected with 
the mutant virus was isolated using the RNeasy RNA extraction kit (Qiagen Valencia, 
CA).  RT was carried out using the primer 17TG with the sequence 5' 
TTTTTTTTTTTTTTTTTG, which should select any mRNA with a C residue 5' to the 
poly (A) tail, including viral RNA.  RT reactions were carried out by following 
Invitrogen Carlsbad, CA’s protocol for SuperScript II RNase H- Reverse Transcriptase.  
Five hundred nanograms of 17TG was incubated with 1 !g of total RNA with 1.2mM 
dNTP’s in a volume of 12 !l, incubated at 65°C for 5 minutes and chilled on ice for 2 
minutes.  Following the first incubation step, Invitrogen’s 5X 1st strand buffer 
(Invitrogen Carlsbad, CA) was added to 1X concentration with 10!M DTT and DEPC 
water in a volume of 19!l, this mix was incubated at 42°C for 2 minutes then 200 units 
(1!l) of SuperScript II was added and incubated at 42°C for 50 minutes (Invitrogen 
Carlsbad, CA). The RT was heat inactivated at 70°C for 15 minutes.  PCR for 
sequencing reactions was carried out using the B36For 
(5'TAGTACTCTACCTGGTTTT) and 17TG primers under the conditions: 34 cycles of 
 109 
95ºC for 30 seconds, 40ºC for 60 seconds and 72ºC for 60 seconds, followed by a final 
extension for 15 minutes at 72ºC.  A total of 4 PCR reactions were combined and gel 
purified using the Wizard PCR purification kit (Promega Madison, WI) quantitated and 
sequenced using the primer 5666 (5'GTAGTGCCAGATGGGTTA), and the Big Dye 
Terminator kit (ABI Foster City, CA).  Sequencing was performed on 600 ng of gel 
purified material under the following cycle conditions: preheat thermocycler to 96°C 
then 98°C for 30 seconds, 50°C for 15 seconds, 60°C for 4 minutes, repeated 24 times.  
Unincorporated nucleotides were removed using Micro-Spin 30 columns (Bio-Rad 
Hercules, CA).  Columns were warmed to room temperature and tapping cleared any 
bubbles.  The columns were allowed to settle for 30 minutes and the plug was removed 
from the bottom.  The columns were then centrifuged at 100 xG for 2 minutes.  Columns 
were removed and place in fresh tubes.  The sequencing reaction was added and 
centrifuged again at 700 xG for two minutes.  The columns were discarded and the 
reaction was dried completely and taken to the Gene Technologies Laboratory at Texas 
A&M University Department of Biology.  The program Sequencher (Gene Codes 
Corporation Ann Arbor MI) was used to evaluate the sequences. 
Growth curves.  If mutant virus is obtained growth curves will be carried out in order to 
determine the effects of our mutations on viral replication.  17Cl-1 monolayers will be 
infected with an equivalent M.O.I. of each mutant was well as wild type A59 virus.  At 
time points 2, 4, 6, 12, 24, and 48 hours.  Virus production was quantitated by plaque 
assay on L2 monolayers overlayed with 0.8% agarose and stained with crystal violet 2 g 
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crystal violet (Sigma St. Louis, MO) 800 ml methanol (EM Science Gibbstown, NJ), and 
200 ml water, and quantitated. 
Results 
To date we have successfully introduced the mutations MT2A, ATW5', ATW3', ATW, 
MT3C, M24C, and 24C into the MHV G fragment by restriction fragment exchange.  
Putative mutant positive plasmids were screened by Esp 3I (US Biological Swampscott 
MA), and by sequencing using the conditions described in Materials and Methods.  
Mutants ATW3' and MT3C have been constructed into the infectious clone system and 
were apparently viable.  The viruses need to be plaque purified and sequenced to 
confirm the retention of the intended mutation.  After the sequence of the 3' UTR has 
been established growth curves will be carried out as described in Materials and 
Methods. 
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CHAPTER VI 
 
CONCLUSIONS 
 
 
Discussion 
 
 The goal of this dissertation was to determine the structural requirements for the 
3' terminal 42 nucleotide host protein binding element in MHV replication.  A mutagenic 
study of the 3' terminal 42 nucleotide host protein binding element demonstrated that 
primary and secondary structure both play a role in host protein binding to viral RNA.  
Compensatory mutants that restored wild type computer predicted secondary structure 
were developed and restored host protein binding.  Two mutants were developed that 
bound protein at elevated levels when compared to wild type probe.   
 Comparisons between the computer predicted RNA secondary structure models 
of the wild type 3' terminal 42 nucleotide and enzymatic probing data of the 3' terminal 
166 nucleotides reveals that the 42 nucleotide model matches the digestion data more 
accurately than the computer predicted model for the 3' terminal 166 nucleotides, 
suggesting that the wild type secondary structure predicted for the 3' terminal 42 
nucleotides may form in a larger RNA molecule. 
 In order to determine the biological effects of the mutants developed, targeted 
recombination was performed in an attempt to introduce these mutations into infectious 
virions.  The results of targeted recombination indicate that the primary structure of the 
3' terminal 42 nucleotide host protein binding element was strongly selected for.  RNA 
molecules that recombined to restore wild type primary and secondary structure of the 3' 
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terminal 42 nucleotide host protein binding element were able to replicate and were 
selected. 
 Although we were unable to introduce these mutations into viruses by targeted 
recombination it was possible to examine their effect on RNA replication utilizing DI 
RNA’s.  DI RNA’s carrying mutations within the 3' terminal 42 nucleotide host protein 
binding motif were unable to produce positive strand DI that could be detected in our 
assays.  Negative strand DI RNA was sequenced in order to determine what replicated 
and three of the mutants that apparently replicated had recombined to restore wild type 
primary structure in all three experiments attempted.  One of these mutants, MT3C, had 
been tested by Yu and Leibowitz in DIssE and it also recombined to restore wild type 
secondary structure and DI RNA positive strand synthesis (110).  The other 3 mutants 
tested were also unable to produce detectable levels of positive strand DI B36.  
Sequencing demonstrated that the mutations were maintained and semi-quantitative RT-
PCR demonstrated that negative strand synthesis was not adversely affected by the 
mutations introduced.  It is worth noting that the DI RNA’s that could synthesize 
negative strand only had one point mutation within the 11 nucleotide motif, and the other 
mutations in those mutants lay outside the region.  These results indicate that 
conservation of primary structure in the 11 nucleotide motif is necessary for DI RNA 
replication.  However in one experiment positive strand DI RNA did replicate, and upon 
sequencing it was discovered that partial restoration of primary structure occurred.  
Indicating that at least some of the point mutants introduced had no effect, while others 
were deleterious. 
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 In order to establish the effect of the mutations on viral replication the MHV-A59 
infectious cDNA clone developed by Baric’s lab was mutated (108).  Mutants of the 3' 
terminal 42 nucleotide host protein binding element that had the greatest decrease in host 
protein binding, and the greatest increase in host protein binding were engineered into 
the G fragment of the infectious clone.  Mutant G fragment was assembled into the full-
length cDNA, transcribed and introduced into cells that support MHV replication.  
Initially each mutant virus was viable, but sequence and titers of the cloned viruses have 
not been established. 
 Previous work on MHV has established the importance of host proteins 
interacting with the MHV genome.  PTB binds to the leader RNA as well as the 5' end of 
the genome complement, data suggests PTB is important for MHV transcription (35, 
52).  It has recently been demonstrated that over-expression of PTB decreases viral 
mRNA transcription but not translation (17).  PTB also alters RNA secondary structure 
and may help mediate 5' to 3' interactions of the MHV genome through PTB interactions 
with hnRNP-A1(36).  hnRNP-A1 interacts with the TRS and 3' UTR; DI mutants with 
decreased hnRNPA-1 binding also had a decrease in transcription and replication (36, 
36, 53)  
 Spagnolo and Hogue characterized an interaction between the poly A tail of DI’s 
and PABP.  PABP is a host cellular protein that is required for translation of eukaryotic 
mRNA’s.  PABP has been shown to interact with eIF4G in stimulating translation and 
circularization of mRNA’s.  Herold and Andino established that PABP interaction with 
the poly (A) tail of the poliovirus genome resulted in circularization of the genome that 
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resulted in the initiation of complementary strand RNA synthesis (32).  It is likely that 
PABP binding to the MHV 3' UTR has a similar effect on virus replication as Spagnolo 
and Hogue hypothesize (93).  Further work on PABP interactions with poliovirus 
genome suggests that the circularized genome is translationally active. Support for 
PABP mediated circularization of viral genomes comes from Svitkin et. al. who 
demonstrated that the PABP eIF4G interaction was essential for translation (97), another 
supporting study showed that cleavage of eIF4G by poliovirus proteins will stop 
translation of the poliovirus genome (65).  For MHV it is possible that PABP, PTB, and 
hnRNP-A1 all interact to form the protein-protein bridge necessary for viral 
complementary strand synthesis.   
To date, no interaction between PABP, PTB, and hnRNP-A1 has been 
established in MHV although there is support for PTB and hnRNP-A1 interactions.  If it 
were found that PABP binds to either PTB or hnRNP-A1 it would help establish the 
circularization of MHV as an essential step for virus replication.  In order to test if PTB, 
hnRNP-A1, and PABP interact co-immunoprecipitation assays could be performed.  If 
an interaction is established then the poliovirus 3C protease that cleaves PABP could be 
selectively expressed in MHV infected cells.  If the interaction results in cessation of 
translation then cleavage of PABP would result in a deleterious phenotype and the 
effects could be measured by western blot for MHV proteins.  If PABP plays another 
role in the MHV lifecycle cells expressing 3C protease could be used to determine if 
PABP influences replication or negative strand synthesis. 
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 Nanda and Leibowitz established the identity of four proteins that specifically 
interact with the MHV 3' terminal 42 nucleotide host protein binding element as 
mitochondrial aconitase, mitochondrial HSP70, HSP60, and HSP40 (68).  They also 
established that metabolic regulation of the RNA binding activity of mitochondrial 
aconitase did influence viral growth.  Mitochondrial aconitase has a cytosolic 
counterpart that is a conditional RNA binding protein, iron regulatory protein (IRP).  
IRP regulates the translation of ferritin and transferrin through specific interactions with 
the 5' and 3' UTR’s of each mRNA depending upon the iron concentration of the cell.  
By increasing iron concentration of the cell Nanda and Leibowitz were able to increase 
the amount of mitochondrial aconitase in the cell which may have influenced the RNA 
binding properties of mitochondrial aconitase and increased viral titer compared to virus 
infected cells that did not receive iron treatment at early times post infection. 
 The results described here demonstrate the role of the 3' terminal 42 nucleotide 
host protein binding element in viral RNA replication.  Mutants of the 3' terminal 42 
nucleotide host protein binding element were readily selected against in targeted 
recombination experiments, and again in DI replication experiments.  Three of the 
mutants generated were maintained in DI replication assays, but these mutants were 
defective in positive strand synthesis.  The positive strand defective phenotype explains 
the inability to isolate mutant virus from targeted recombination.  It is also possible that 
the 11 nucleotide motif is required for initiation of negative strand synthesis.  Mutations 
outside the region accumulated negative strand, while mutations within the 11 nucleotide 
motif were recombined back to wild type.  Although in the infectious cDNA construct 
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the mutants generated virus, but these viruses have not yet been sequenced or compared 
to wild type virus in growth curve experiments.   
The exact mechanism for the host protein interaction has not been characterized, 
but it is possible that binding of the mitochondrial aconitase complex to the 11 
nucleotide motif is a necessary signal for another complex of proteins to interact and 
begin negative strand synthesis.  It is possible that the other proteins which bind the 5' 
and 3' UTR’s interacted as proposed, the genome circularized as predicted, but the 
initiation signal for negative strand synthesis did not occur due to the missing 
mitochondrial aconitase complex.  Another possibility is that the mitochondrial aconitase 
complex binding initiates a conformational change in concert with the secondary 
structure change described for PTB (35).  Since the mitochondrial aconitase complex did 
not bind, the proper RNA conformation for negative strand synthesis was not achieved.  
Without the proper conglomeration of RNA, host proteins, and viral proteins the 
appropriate signal for negative strand synthesis was absent so no negative strand 
synthesis occurred.   
Results from Lin et. al. identified the signal for complementary strand synthesis 
as the 3' terminal 55 nucleotides (55).  The complementary strand synthesis signal was 
identified by a deletion mutant of the 3' terminal 55 nucleotides, not a mutagenic study 
of the same region.  Obviously the 3' terminal 42 nucleotide element resides within the 3' 
terminal 55 nucleotides and the 11 nucleotide motif is present therein.  It is likely that by 
deleting the 3' terminal 42 nucleotide element of the 3' UTR Lin et al. removed signals 
for positive and negative strand synthesis.  Had the 11 nucleotide motif remained intact 
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it is possible that they would have seen complementary strand synthesis.  Lin et al 
demonstrate that the upstream 11 nucleotide motif was not sufficient for negative strand 
synthesis, if the upstream sequence was sufficient the 55 3' terminal deletion would have 
generated complementary strand RNA.   
It is possible that the 11 nucleotide motif is the initiation signal for 
complementary strand synthesis and that a cis-acting sequence composed of the 
nucleotides from the end of the 11 nucleotide motif to the beginning of the poly (A) tail 
contain the signal for genomic RNA synthesis.  DI replication assays ascertained that 
mutations outside of the 11 nucleotide motif did not effect complementary strand 
synthesis but only effected positive strand synthesis.  Suggesting a role for other motifs 
in the 3' terminal 42 nucleotide host protein binding element as necessary signals for 
positive strand synthesis. 
In order to investigate the possible mechanisms of initiation of negative strand 
synthesis the infectious clone could be used to develop a panel of mutants with single 
point mutations to precisely define the structural requirements for viral replication.  If 
mutants that did not replicate were developed then strand specific northern blot analyses 
could be performed to determine if complementary strand RNA was produced.  In order 
to establish a specific interaction between the protein in question and the RNA probes 
containing the same mutations introduced into the cDNA infectious clone could be 
assayed by gel shift.  Another approach to show a specific interaction inside an infected 
cell would be to establish a time-course of host protein interacting with the 3' terminal 42 
nucleotide element with mitochondrial aconitase or one of the other proteins of the 
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complex.  Immunoprecipitation-RT-PCR and sequencing to determine the origin of the 
RNA captured could be applied.  Another approach would be to expose radiolabeled 
mutant virus infected cells to UV light, cross-linking any protein:nucleic acid interaction 
and immunoprecipitate with antibodies to mitochondrial aconitase.  If a viral 
RNA:protein interaction occurred then the immunoprecipitation product would be 
readily detectable.  This data could be matched kinetically by appearance of 
complementary strand RNA, mRNA, or genomic RNA as detected by strand specific 
northern blot or RPA on an identical time course. 
An approach to determine a specific protein’s role in virus replication is to use 
siRNAs and block specific host proteins at translation, infect cells and perform growth 
curves to establish roles in virus growth.  If effective deletion of a specific protein 
resulted in the impedance of replication, then real time PCR could be used to determine 
if the effect was on transcription, negative strand synthesis or positive strand synthesis.  
If it was found that the effect was not on viral replication or transcription then western 
Blot could be used to determine a role in translation.  It is also possible that the protein 
binding plays a role in packaging of the viral genome, so EM studies could be used to 
identify the build up of viral RNA’s. 
Since the roles of the proteins identified in MHV replication have not been 
precisely identified it is possible that many of the proteins that bind to the 5' and 3' 
UTR’s could act to protect viral RNA from degradation.  Spangberg et. al. used an in 
vitro protection system to establish the role of La antigen in binding to the HCV 3' UTR 
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(95).  Such a system could be used to define the role of PABP, hnRNP-A1, PTB, and the 
mitochondrial aconitase complex. 
Another uncharacterized aspect of host protein binding to specific RNA 
secondary structures in the 3' terminal 42 nucleotide host protein binding element is 
whether the secondary structure forms first or if the protein binding forces a 
conformational change.  A study of poly (C) binding protein, demonstrated that the HCV 
IRES must take shape first then poly (C) binding protein will attach.  Poly(C ) binding 
proteins role in HCV replication is unknown at this time (94).  Conversely, PTB binding 
to the 3' UTR is thought to mediate a conformational change in MHV (35).  If binding 
forces an RNA conformational change in order to initiate negative strand synthesis, it is 
possible that the change in conformation drives not only RNA:protein interactions but 
RNA:RNA interactions as well.  Binding of the mitochondrial aconitase complex may 
open up an RNA binding site for a helicase.  The helicase then initiates unfolding of the 
positive strand which in turn allows the replicase proteins to bind resulting in production 
of the strand full-length complementary strand RNA. 
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